<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Diabetes Obes Metab</journal-id><journal-id journal-id-type="iso-abbrev">Diabetes Obes Metab</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)1463-1326</journal-id><journal-id journal-id-type="publisher-id">DOM</journal-id><journal-title-group><journal-title>Diabetes, Obesity &#x00026; Metabolism</journal-title></journal-title-group><issn pub-type="ppub">1462-8902</issn><issn pub-type="epub">1463-1326</issn><publisher><publisher-name>Blackwell Publishing Ltd</publisher-name><publisher-loc>Oxford, UK</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28318098</article-id><article-id pub-id-type="pmc">5607085</article-id><article-id pub-id-type="doi">10.1111/dom.12947</article-id><article-id pub-id-type="publisher-id">DOM12947</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Decreased insulin&#x02010;stimulated brown adipose tissue glucose uptake after short&#x02010;term exercise training in healthy middle&#x02010;aged men</article-title><alt-title alt-title-type="right-running-head">MOTIANI <sc>et al.</sc></alt-title><alt-title alt-title-type="left-running-head">MOTIANI <sc>et al.</sc></alt-title></title-group><contrib-group><contrib id="dom12947-cr-0001" contrib-type="author"><name><surname>Motiani</surname><given-names>Piryanka</given-names></name><degrees>MD, PhD</degrees><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2876-1851</contrib-id><xref ref-type="aff" rid="dom12947-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="dom12947-cr-0002" contrib-type="author"><name><surname>Virtanen</surname><given-names>Kirsi A.</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="dom12947-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="dom12947-cr-0003" contrib-type="author"><name><surname>Motiani</surname><given-names>Kumail K.</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="dom12947-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="dom12947-cr-0004" contrib-type="author"><name><surname>Eskelinen</surname><given-names>Joonas J.</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="dom12947-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="dom12947-cr-0005" contrib-type="author"><name><surname>Middelbeek</surname><given-names>Roeland J.</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="dom12947-aff-0002">
<sup>2</sup>
</xref><xref ref-type="aff" rid="dom12947-aff-0003">
<sup>3</sup>
</xref></contrib><contrib id="dom12947-cr-0006" contrib-type="author"><name><surname>Goodyear</surname><given-names>Laurie J.</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="dom12947-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="dom12947-cr-0007" contrib-type="author"><name><surname>Savolainen</surname><given-names>Anna M.</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="dom12947-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="dom12947-cr-0008" contrib-type="author"><name><surname>Kemppainen</surname><given-names>Jukka</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="dom12947-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="dom12947-aff-0004">
<sup>4</sup>
</xref></contrib><contrib id="dom12947-cr-0009" contrib-type="author"><name><surname>Jensen</surname><given-names>J&#x000f8;rgen</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="dom12947-aff-0005">
<sup>5</sup>
</xref></contrib><contrib id="dom12947-cr-0010" contrib-type="author"><name><surname>Din</surname><given-names>Mueez U.</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="dom12947-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="dom12947-cr-0011" contrib-type="author"><name><surname>Saunavaara</surname><given-names>Virva</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="dom12947-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="dom12947-aff-0006">
<sup>6</sup>
</xref></contrib><contrib id="dom12947-cr-0012" contrib-type="author"><name><surname>Parkkola</surname><given-names>Riitta</given-names></name><xref ref-type="aff" rid="dom12947-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="dom12947-aff-0007">
<sup>7</sup>
</xref></contrib><contrib id="dom12947-cr-0013" contrib-type="author"><name><surname>L&#x000f6;yttyniemi</surname><given-names>Eliisa</given-names></name><xref ref-type="aff" rid="dom12947-aff-0008">
<sup>8</sup>
</xref></contrib><contrib id="dom12947-cr-0014" contrib-type="author"><name><surname>Knuuti</surname><given-names>Juhani</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="dom12947-aff-0009">
<sup>9</sup>
</xref></contrib><contrib id="dom12947-cr-0015" contrib-type="author"><name><surname>Nuutila</surname><given-names>Pirjo</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="dom12947-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="dom12947-aff-0010">
<sup>10</sup>
</xref></contrib><contrib id="dom12947-cr-0016" contrib-type="author"><name><surname>Kalliokoski</surname><given-names>Kari K.</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="dom12947-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="dom12947-cr-0017" contrib-type="author" corresp="yes"><name><surname>Hannukainen</surname><given-names>Jarna C.</given-names></name><degrees>PhD</degrees><address><email>jarna.hannukainen@tyks.fi</email></address><xref ref-type="aff" rid="dom12947-aff-0001">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="dom12947-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Turku PET Centre</named-content>
<institution>University of Turku</institution>
<named-content content-type="city">Turku</named-content>
<country country="FI">Finland</country>
</aff><aff id="dom12947-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Section on Integrative Physiology and Metabolism</named-content>
<institution>Joslin Diabetes Center, Harvard Medical School</institution>
<named-content content-type="city">Boston</named-content>
<named-content content-type="country-part">Massachusetts</named-content>
</aff><aff id="dom12947-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Division of Endocrinology, Diabetes and Metabolism</named-content>
<institution>Beth Israel Deaconess Medical Center</institution>
<named-content content-type="city">Boston</named-content>
<named-content content-type="country-part">Massachusetts</named-content>
</aff><aff id="dom12947-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Department of Clinical Physiology and Nuclear Medicine</named-content>
<institution>Turku University Hospital</institution>
<named-content content-type="city">Turku</named-content>
<country country="NO">Finland</country>
</aff><aff id="dom12947-aff-0005">
<label><sup>5</sup></label>
<named-content content-type="organisation-division">Department of Physical Performance</named-content>
<institution>Norwegian School of Sport Sciences</institution>
<named-content content-type="city">Oslo</named-content>
<country country="NO">Norway</country>
</aff><aff id="dom12947-aff-0006">
<label><sup>6</sup></label>
<named-content content-type="organisation-division">Department of Medical Physics</named-content>
<institution>Turku University Hospital</institution>
<named-content content-type="city">Turku</named-content>
<country country="FI">Finland</country>
</aff><aff id="dom12947-aff-0007">
<label><sup>7</sup></label>
<named-content content-type="organisation-division">Department of Radiology</named-content>
<institution>Turku University Hospital</institution>
<named-content content-type="city">Turku</named-content>
<country country="FI">Finland</country>
</aff><aff id="dom12947-aff-0008">
<label><sup>8</sup></label>
<named-content content-type="organisation-division">Department of Biostatistics</named-content>
<institution>University of Turku</institution>
<named-content content-type="city">Turku</named-content>
<country country="FI">Finland</country>
</aff><aff id="dom12947-aff-0009">
<label><sup>9</sup></label>
<named-content content-type="organisation-division">Turku PET Centre</named-content>
<institution>&#x000c5;bo Akademi University</institution>
<named-content content-type="city">Turku</named-content>
<country country="FI">Finland</country>
</aff><aff id="dom12947-aff-0010">
<label><sup>10</sup></label>
<named-content content-type="organisation-division">Department of Endocrinology</named-content>
<institution>Turku University Hospital</institution>
<named-content content-type="city">Turku</named-content>
<country country="FI">Finland</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold> Jarna C. Hannukainen PhD, Turku PET Centre, University of Turku, Turku PO Box 52, FIN&#x02010;20521, Finland. Email: <email>jarna.hannukainen@tyks.fi</email></corresp></author-notes><pub-date pub-type="epub"><day>06</day><month>7</month><year>2017</year></pub-date><pub-date pub-type="ppub"><month>10</month><year>2017</year></pub-date><volume>19</volume><issue>10</issue><issue-id pub-id-type="doi">10.1111/dom.2017.19.issue-10</issue-id><fpage>1379</fpage><lpage>1388</lpage><history><date date-type="received"><day>19</day><month>1</month><year>2017</year></date><date date-type="rev-recd"><day>03</day><month>3</month><year>2017</year></date><date date-type="accepted"><day>15</day><month>3</month><year>2017</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2017 John Wiley & Sons Ltd <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2017 The Authors. <italic>Diabetes, Obesity and Metabolism</italic> published by John Wiley &#x00026; Sons Ltd.</copyright-statement><license license-type="creativeCommonsBy-nc"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">Creative Commons Attribution&#x02010;NonCommercial</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="file:DOM-19-1379.pdf"/><abstract id="dom12947-abs-0001"><sec id="dom12947-sec-0001"><title>Aims</title><p id="dom12947-para-0001">To test the hypothesis that high&#x02010;intensity interval training (HIIT) and moderate&#x02010;intensity continuous training (MICT) improve brown adipose tissue (BAT) insulin sensitivity.</p></sec><sec id="dom12947-sec-0002"><title>Participants and methods</title><p id="dom12947-para-0002">Healthy middle&#x02010;aged men (n = 18, age 47 years [95% confidence interval {CI} 49, 43], body mass index 25.3 kg/m<sup>2</sup> [95% CI 24.1&#x02010;26.3], peak oxygen uptake (VO<sub>2peak</sub>) 34.8 mL/kg/min [95% CI 32.1, 37.4] ) were recruited and randomized into six HIIT or MICT sessions within 2 weeks. Insulin&#x02010;stimulated glucose uptake was measured using 2&#x02010;[<sup>18</sup>F]flouro&#x02010;2&#x02010;deoxy&#x02010;D&#x02010;glucose positron&#x02010;emission tomography in BAT, skeletal muscle, and abdominal and femoral subcutaneous and visceral white adipose tissue (WAT) depots before and after the training interventions.</p></sec><sec id="dom12947-sec-0003"><title>Results</title><p id="dom12947-para-0003">Training improved VO<sub>2peak</sub> (<styled-content style="italic-in-any-context">P</styled-content> = .0005), insulin&#x02010;stimulated glucose uptake into the quadriceps femoris muscle (<styled-content style="italic-in-any-context">P</styled-content> = .0009) and femoral subcutaneous WAT (<styled-content style="italic-in-any-context">P</styled-content> = .02) but not into BAT, with no difference between the training modes. Using pre&#x02010;intervention BAT glucose uptake, we next stratified subjects into high BAT (&#x0003e;2.9 &#x000b5;mol/100 g/min; n = 6) or low BAT (&#x0003c;2.9 &#x000b5;mol/100 g/min; n = 12) groups. Interestingly, training decreased insulin&#x02010;stimulated BAT glucose uptake in the high BAT group (4.0 [2.8, 5.5] vs 2.5 [1.7, 3.6]; training*BAT, <styled-content style="italic-in-any-context">P</styled-content> = .02), whereas there was no effect of training in the low BAT group (1.5 [1.2, 1.9] vs 1.6 [1.2, 2.0] &#x000b5;mol/100 g/min). Participants in the high BAT group had lower levels of inflammatory markers compared with those in the low BAT group.</p></sec><sec id="dom12947-sec-0004"><title>Conclusions</title><p id="dom12947-para-0004">Participants with functionally active BAT have an improved metabolic profile compared with those with low BAT activity. Short&#x02010;term exercise training decreased insulin&#x02010;stimulated BAT glucose uptake in participants with active BAT, suggesting that training does not work as a potent stimulus for BAT activation.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="dom12947-kwd-0001">brown adipose tissue</kwd><kwd id="dom12947-kwd-0002">exercise training</kwd><kwd id="dom12947-kwd-0003">glucose uptake</kwd><kwd id="dom12947-kwd-0004">free fatty acid uptake</kwd><kwd id="dom12947-kwd-0005">positron emission tomography</kwd></kwd-group><funding-group><award-group><funding-source>Academy of Finland</funding-source><award-id>251399</award-id><award-id>256470</award-id></award-group><award-group><funding-source>University of Turku</funding-source></award-group><award-group><funding-source>Turku University Hospital</funding-source></award-group><award-group><funding-source>&#x000c5;bo Akademi University</funding-source></award-group><award-group><funding-source>European Foundation for the Study of Diabetes</funding-source></award-group><award-group><funding-source>Emil Aaltonen Foundation</funding-source></award-group><award-group><funding-source>Hospital District of Southwest Finland</funding-source></award-group><award-group><funding-source>Orion Research Foundation</funding-source></award-group><award-group><funding-source>Finnish Diabetes Foundation</funding-source></award-group><award-group><funding-source>Ministry of Education of the State of Finland</funding-source></award-group><award-group><funding-source>EU FP7 project DIABAT</funding-source><award-id>HEALTH&#x02010;F2&#x02010;2011&#x02010;278373</award-id></award-group><award-group><funding-source>Paavo Nurmi Foundation</funding-source></award-group><award-group><funding-source>Novo Nordisk Foundation</funding-source></award-group><award-group><funding-source>National Institutes of Health</funding-source><award-id>R01&#x02010;DK099511</award-id><award-id>RO1&#x02010;DK112283</award-id></award-group><award-group><funding-source>Joslin Diabetes Center DERC</funding-source><award-id>5P30DK36836</award-id><award-id>T32&#x02010;DK&#x02010;07260&#x02010;038</award-id></award-group></funding-group><counts><fig-count count="3"/><table-count count="2"/><page-count count="10"/><word-count count="7072"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>component-id</meta-name><meta-value>dom12947</meta-value></custom-meta><custom-meta><meta-name>header-id</meta-name><meta-value>dom12947-hdr-0001</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>October 2017</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.2.1 mode:remove_FC converted:12.10.2017</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="self-citation" id="dom12947-cit-1001">
<string-name>
<surname>Motiani</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Virtanen</surname>
<given-names>KA</given-names>
</string-name>, <string-name>
<surname>Motiani</surname>
<given-names>KK</given-names>
</string-name>, <string-name>
<surname>Eskelinen</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Middelbeek</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Goodyear</surname>
<given-names>LJ</given-names>
</string-name>, <string-name>
<surname>Savolainen</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Kemppainen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Jensen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Din</surname>
<given-names>MU</given-names>
</string-name>, <string-name>
<surname>Saunavaara</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Parkkola</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>L&#x000f6;yttyniemi</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Knuuti</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Nuutila</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Kalliokoski</surname>
<given-names>KK</given-names>
</string-name> and <string-name>
<surname>Hannukainen</surname>
<given-names>JC</given-names>
</string-name>. <article-title>Decreased insulin&#x02010;stimulated brown adipose tissue glucose uptake after short&#x02010;term exercise training in healthy middle&#x02010;aged men</article-title>. <source>Diabetes Obes Metab</source>. <year>2017</year>;19:1379&#x02013;1388. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/dom.12947">https://doi.org/10.1111/dom.12947</ext-link>
</mixed-citation>
</p><fn-group><fn id="dom12947-note-0101"><p>
<bold>Funding Information</bold> This study was supported by the Academy of Finland, the University of Turku, Turku University Hospital, and &#x000c5;bo Akademi University. The study was also financially supported by the European Foundation for the Study of Diabetes, the Emil Aaltonen Foundation, the Hospital District of Southwest Finland, the Orion Research Foundation, the Finnish Diabetes Foundation, the Ministry of Education of the State of Finland, the Academy of Finland (grants 251399 and 256470), EU FP7 project DIABAT (HEALTH&#x02010;F2&#x02010;2011&#x02010;278373), the Paavo Nurmi Foundation, the Novo Nordisk Foundation, and National Institutes of Health Grants R01&#x02010;DK099511 and RO1&#x02010;DK112283 (to L. J. G.), 5P30DK36836 (Joslin Diabetes Center DERC) and T32&#x02010;DK&#x02010;07260&#x02010;038 (to R. J. W. M)</p></fn></fn-group></notes></front><body><sec id="dom12947-sec-0005"><label>1</label><title>INTRODUCTION</title><p id="dom12947-para-0005">Brown adipose tissue (BAT) has an exceptional thermogenic potential attributable to mitochondrial uncoupling protein 1 (UCP&#x02010;1).<xref rid="dom12947-bib-0001" ref-type="ref">1</xref>, <xref rid="dom12947-bib-0002" ref-type="ref">2</xref> BAT is suggested to regulate energy balance in humans, and enhance glucose homeostasis and insulin sensitivity, and thus may be a potential therapeutic target for obesity and insulin resistance.<xref rid="dom12947-bib-0003" ref-type="ref">3</xref>, <xref rid="dom12947-bib-0004" ref-type="ref">4</xref> BAT is activated by cold exposure, and other stimuli, including insulin.<xref rid="dom12947-bib-0005" ref-type="ref">5</xref>, <xref rid="dom12947-bib-0006" ref-type="ref">6</xref> The effects of exercise training on BAT activity in humans are incompletely understood.</p><p id="dom12947-para-0006">It is well known that regular exercise improves skeletal muscle insulin sensitivity and whole&#x02010;body homeostasis. We have shown that high&#x02010;intensity interval training (HIIT) and moderate&#x02010;intensity continuous training (MICT) improve both whole&#x02010;body and skeletal muscle insulin&#x02010;stimulated glucose uptake.<xref rid="dom12947-bib-0007" ref-type="ref">7</xref> Limited studies have investigated the effects of exercise on BAT glucose uptake in humans, and the data, thus far, have not been consistent. One study showed higher BAT glucose uptake in people with cancer who had higher self&#x02010;reported physical activity compared with those who were sedentary.<xref rid="dom12947-bib-0008" ref-type="ref">8</xref> Another study showed significantly lower cold&#x02010;induced BAT glucose uptake in trained athletes compared with sedentary men.<xref rid="dom12947-bib-0009" ref-type="ref">9</xref> Both of these studies, however, were cross&#x02010;sectional investigations, and studies directly determining the effects of exercise training on BAT glucose uptake are lacking. In addition, while there has been considerable investigation into the effects of exercise training on glucose metabolism in humans, data on the effects of exercise training on fatty acid metabolism in white adipose tissue (WAT) and BAT have been much more limited.</p><p id="dom12947-para-0007">The aim of the present study was to determine if exercise training alters insulin&#x02010;stimulated glucose uptake in BAT. In addition, we determined if the intensity and duration of exercise training affected BAT metabolism. Sedentary middle&#x02010;aged men (n = 18) completed 2 weeks of HIIT or MICT training. Pre&#x02010; and post&#x02010;training insulin&#x02010;stimulated glucose uptake and fasting free fatty acid (FFA) uptake were determined in BAT, WAT depots and skeletal muscle using 2&#x02010;[<sup>18</sup>F]flouro&#x02010;2&#x02010;deoxy&#x02010;D&#x02010;glucose (FDG) and 14(R,S)&#x02010;[<sup>18</sup>F]fluoro&#x02010;6&#x02010;thia&#x02010;heptadecanoic acid (FTHA) and positron&#x02010;emission tomography (PET)/computed tomography (CT). We hypothesized that HIIT exercise training activates BAT, resulting in enhanced insulin&#x02010;stimulated glucose uptake, and that MICT exercise training increases BAT activity to a lesser extent. Furthermore, we investigated whether BAT activity was related to metabolic profile.</p></sec><sec id="dom12947-sec-0006"><label>2</label><title>PARTICIPANTS AND METHODS</title><p id="dom12947-para-0008">A total of 28 healthy middle&#x02010;aged sedentary men (age 40&#x02010;55 years, body mass index 18.5&#x02010;30 kg/m<sup>2</sup>, peak oxygen uptake [VO<sub>2Peak</sub>] 40 mL/kg/min) were randomized into two groups: HIIT (n = 14) or MICT (n = 14). The study was approved by the local ethics committee of the hospital district of South&#x02010;Western Finland and was carried out in compliance with the Declaration of Helsinki. Informed consent was obtained before any measurements were performed. The recruitment process, and inclusion and exclusion criteria have been described previously.<xref rid="dom12947-bib-0010" ref-type="ref">10</xref> In 7 participants supraclavicular PET scanning was not possible because of technical difficulties. During the training intervention, 2 participants withdrew from the HIIT group; 1 because of training&#x02010;induced hip pain, and 1 because of illness. One participant from the MICT group withdrew for personal reasons (total n = 18; HIIT, n = 7 and MICT, n = 11; Figure <xref rid="dom12947-fig-0001" ref-type="fig">1</xref>A,B). The present study is part of a larger study titled, &#x0201c;The effects of short&#x02010;term high intensity interval training on tissue glucose and fat metabolism in healthy subjects and in patients with type 2 diabetes&#x0201d; (<ext-link ext-link-type="uri" xlink:href="http://Clinicaltrials.gov">Clinicaltrials.gov</ext-link> #NCT01344928).</p><fig fig-type="Figure" xml:lang="en" id="dom12947-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>A, Study design for the sub&#x02010;study of the larger HITPET (NCT01344928) study project including 18 healthy middle&#x02010;aged men randomized into two training programmes, HIIT and MICT. B, Study design showing the division of subjects into high BAT and low BAT activity groups. OGTT, oral glucose tolerance test</p></caption><graphic id="nlm-graphic-1" xlink:href="DOM-19-1379-g002"/></fig><sec id="dom12947-sec-0007"><label>2.1</label><title>Study design</title><p id="dom12947-para-0009">At the initial screening visit, physical examination, ECG, blood sampling, a fasting 2&#x02010;hour 75&#x02010;g oral glucose tolerance test, and VO<sub>2peak</sub> were performed. On the first study day, MRI and fasting [<sup>18</sup>F]FTHA&#x02010;PET/CT scanning were performed, and on the second day we performed [<sup>18</sup>F]FDG&#x02010;PET/CT scanning during a euglycaemic&#x02013;hyperinsulinaemic clamp. These studies were repeated after the 2&#x02010;week exercise intervention, starting with the [<sup>18</sup>F]&#x02010;FTHA&#x02010;PET study at <bold>~</bold>48 hours, followed by a [<sup>18</sup>F]FDG&#x02010;PET study at <bold>~</bold>72 hours and an oral glucose tolerance test, and VO<sub>2peak</sub> test <bold>~</bold>96 hours after the last training session.</p></sec><sec id="dom12947-sec-0008"><label>2.2</label><title>
PET studies</title><p id="dom12947-para-0010">The PET/CT images were acquired using GE Discovery TM ST System (General Electric Medical Systems, Milwaukee, Wisconsin). The participants fasted &#x02265;12 hours before the PET studies, and avoided physical activity and both caffeinated and alcoholic drinks for 48 hours before the PET scans. More detailed information is provided in Appendix S1.</p></sec><sec id="dom12947-sec-0009"><label>2.3</label><title>Euglycaemic&#x02013;hyperinsulinaemic clamp, exercise intervention, VO<sub>2peak</sub> test and indirect calorimetry</title><p id="dom12947-para-0011">The euglycaemic&#x02013;hyperinsulinaemic clamp technique was used as described previously.<xref rid="dom12947-bib-0007" ref-type="ref">7</xref> The FDG&#x02010;PET study was performed when the participant reached the stable glucose concentrations at the level of 5 mmol/L (within 5% range for at least 15 minutes) after positioning into the PET scanner. Whole&#x02010;body insulin&#x02010;stimulated glucose uptake rate (M&#x02010;value) was calculated from the measured glucose values collected at steady&#x02010;state during the PET scan. Participants were randomized into HIIT and MICT exercise intervention protocols. These protocols consisted of 6 training sessions over a period of 2 weeks. Sessions 1 and 2 consisted of 4 &#x000d7; 30 seconds of all&#x02010;out cycling bouts with 4 minutes of recovery between the bouts (Monark Ergomedic 828E; Monark, Vansbro, Sweden). Sessions 3 and 4 consisted of 5 bouts and sessions 5 and 6 consisted of 6 bouts. Each bout started with 5&#x02010;second acceleration to maximum cadence without any resistance, followed by an immediate increase of the load (7.5% of whole&#x02010;body weight in kg) for 30 seconds. A MICT session consisted of cycling at an intensity of 60% of VO<sub>2peak</sub> (Tunturi E85; Tunturi Fitness, Almere, The Netherlands). The duration of cycling was 40 minutes for sessions 1 and 2, 50 minutes for sessions 3 and 4, and 60 minutes for sessions 5 and 6.<xref rid="dom12947-bib-0010" ref-type="ref">10</xref> VO<sub>2peak</sub> was determined 1 week before the exercise intervention started and ~96 hours after the last exercise session, as described previously.<xref rid="dom12947-bib-0007" ref-type="ref">7</xref> The open&#x02010;system indirect calorimetry (Deltatrac) was used for the measurement of O<sub>2</sub> consumption (VO<sub>2</sub>) and CO<sub>2</sub> production (VCO<sub>2</sub>) to calculate whole&#x02010;body energy expenditure and substrate oxidation rates.<xref rid="dom12947-bib-0011" ref-type="ref">11</xref>, <xref rid="dom12947-bib-0012" ref-type="ref">12</xref>
</p></sec><sec id="dom12947-sec-0010"><label>2.4</label><title>BAT mass calculation</title><p id="dom12947-para-0012">The BAT mass was analysed by thresholding the voxels from all the potential sites of BAT (cervical, supraclavicular and axillary adipose depots) based on Hounsfield units (HU) in the CT image (&#x02010;250 and &#x02010;50 HU). All voxels above 2.9 &#x000b5;mol/100 g/min glucose uptake on parametric PET images were included. Lastly, the volume of all these voxels (cm<sup>3</sup>) was converted into mass using BAT density of 0.92 g/cm<sup>3</sup>.<xref rid="dom12947-bib-0006" ref-type="ref">6</xref>, <xref rid="dom12947-bib-0013" ref-type="ref">13</xref>, <xref rid="dom12947-bib-0014" ref-type="ref">14</xref>
</p></sec><sec id="dom12947-sec-0011"><label>2.5</label><title>Body composition</title><p id="dom12947-para-0013">The MRI scans were carried out using Philips Gyroscan Intera 1.5T CV Nova Dual scanner (Philips, Amsterdam, the Netherlands). Abdominal area axial T1&#x02010;weighted dual fast field echo images (TE 2.3 and 4.7 ms, TR 120 ms, slice thickness 10 mm without gap) were obtained. Abdominal subcutaneous and visceral adipose tissue masses were analysed using SliceOmatic software v.4.3 (<ext-link ext-link-type="uri" xlink:href="http://www.tomovision.com/products/sliceomatic.htm">http://www.tomovision.com/products/sliceomatic.htm</ext-link>). To obtain the tissue mass, the pixel surface area was multiplied by the slice thickness and the density of adipose tissue 0.9196 kg/L.<xref rid="dom12947-bib-0015" ref-type="ref">15</xref> A bioimpedance monitor (InBody 720; Mega Electronics, Kuopio, Finland) was used to measure body fat percentage.</p></sec><sec id="dom12947-sec-0012"><label>2.6</label><title>Other measurements</title><p id="dom12947-para-0014">Serum adipokine concentration of nerve growth factor (NGF), interleukin (IL)&#x02010;6, IL&#x02010;8, leptin, hepatocyte growth factor (HGF), MCP&#x02010;1, and tumour necrosis factor (TNF)&#x02010;&#x003b1; were analysed using the Adipokine Magnetic Bead Panel 2 (Cat#HADK2MAG&#x02010;61K; Millipore, Billerica, Massachusetts) on the Luminex&#x02010;Multiplex analyser (Millipore). Plasma catecholamines were analysed using a Chromsystems reagent kit for HPLC analysis (Chromsystems Instruments and Chemicals GmbH, Munich, Germany) with the Agilent ChemStation chromatography program. Plasma total and HDL cholesterol, triglycerides and glucose were measured from the venous blood samples with an automatized enzymatic assay and insulin using automatized electro&#x02010;chemiluminescence immunoassay (Cobas 8000; Roche Diagnostics GmbH, Mannheim, Germany). LDL cholesterol concentration was calculated using the Friedewald formula.</p></sec><sec id="dom12947-sec-0013"><label>2.7</label><title>Statistical methods</title><p id="dom12947-para-0015">Descriptive statistics are given as model&#x02010;based means and 95% confidence intervals (CIs). Normal distribution of the variables was assessed using the Shapiro&#x02013;Wilk test, and logarithmic transformation was carried out for non&#x02010;normally distributed values (glucose uptake data, muscle and abdominal visceral adipose tissue FFA uptake, BAT mass, insulin levels, HDL, IL&#x02010;6, TNF&#x003b1;, whole&#x02010;body resting energy expenditure and catecholamines). Statistical analyses were performed with hierarchical linear mixed models compound symmetry covariance structure, including 1 within&#x02010;factor (training; before and after intervention in the whole group) interaction term (training*group; the HIIT and MICT groups behaved differently for the change in variable, with significant differences between the training modes) and (training*BAT; the high BAT and low BAT groups behaved differently for the change in variable, with significant difference between them). Missing data points were accounted for by restricted maximum likelihood estimation within the linear mixed models. Correlation analyses were performed between the variables on a whole&#x02010;group level (n = 18) using Pearson's correlation. All values are reported as model&#x02010;based mean (SAS least squares means) values from all of the variables measured before and after training. <italic>P</italic> values &#x0003c; .05 were taken to indicate statistical significance. The analyses were performed using SAS System, version 9.3 for Windows (SAS Institute Inc., Cary, North Carolina).</p></sec></sec><sec id="dom12947-sec-0014"><label>3</label><title>RESULTS</title><sec id="dom12947-sec-0015"><label>3.1</label><title>Effects of HIIT and MICT</title><p id="dom12947-para-0016">There were no differences in anthropometrics and glucose and lipid profiles between HIIT and MICT groups before the intervention (Table S1A,B, Appendix S1). After training, aerobic capacity increased by 6% (training <italic>P</italic> = .0005), and this tended to be higher after HIIT (9.2%) compared with MICT (3.5%) training (training*group <italic>P</italic> = .06). HIIT training lowered LDL cholesterol (training <italic>P</italic> = .0003; training*group <italic>P</italic> = .01), and tended to lower total cholesterol more than MICT training (training <italic>P</italic> = .002; training*group <italic>P</italic> = .06). Both training modes reduced whole&#x02010;body fat percentage by 4% (training <italic>P</italic> = .0005) and visceral fat by 8% (training <italic>P</italic> = .009).</p><p id="dom12947-para-0017">Training improved insulin&#x02010;stimulated glucose uptake in the quadriceps femoris muscle (training <italic>P</italic> = .0009) and in femoral WAT, but training effect was not significantly different between the groups (training <italic>P</italic> = .02; Figure S1A,B, Appendix S1). Training did not change the insulin&#x02010;stimulated glucose uptake rate in BAT, abdominal subcutaneous WAT, or in visceral adipose tissue (Figure S1B, Appendix S1). Exercise training or training mode did not alter FFA uptake in muscle or BAT (Figure S1C,D, Appendix S1). FFA uptake tended to decrease in visceral adipose tissue (training <italic>P</italic> = .07; training*group <italic>P</italic> = .11) and in abdominal subcutaneous WAT, with a trend towards greater decrease after MICT than HIIT (training <italic>P</italic> = .08; training*group <italic>P</italic> = .06; Figure S1D, Appendix S1).</p><p id="dom12947-para-0018">At baseline, BAT glucose uptake correlated inversely with body mass index (r = &#x02010;0.55, <italic>P</italic> = .02), body weight (r = &#x02010;0.61, <italic>P</italic> = .01), and waist circumference (r = &#x02010;0.52, <italic>P</italic> = .03), and positively with HDL cholesterol (r = 0.62, <italic>P</italic> = .01). BAT glucose uptake also correlated with whole&#x02010;body insulin sensitivity (M&#x02010;value; r = 0.64, <italic>P</italic> = .004), quadriceps muscle glucose uptake (r = 0.47, <italic>P</italic> = .04), and visceral fat glucose uptake (r = &#x02010;0.55, <italic>P</italic> = .02). A positive correlation was found between BAT FFA uptake and muscle FFA uptake (r = 0.73, <italic>P</italic> = .002).</p></sec><sec id="dom12947-sec-0016"><label>3.2</label><title>Participants with low and high BAT activity</title><p id="dom12947-para-0019">Brown adipose tissue activity is highly variable between individuals and we have previously proposed that glucose uptake &#x0003e;2.9 &#x000b5;mol/100 g/min represents functionally active BAT during euglycaemic&#x02014;hyperinsulinaemic clamp.<xref rid="dom12947-bib-0005" ref-type="ref">5</xref>, <xref rid="dom12947-bib-0006" ref-type="ref">6</xref> All participants were, therefore, re&#x02010;stratified into high BAT activity (n = 6) and low BAT activity (n = 12) groups, based on the baseline insulin&#x02010;stimulated BAT glucose uptake threshold of 2.9 &#x000b5;mol/100 g/min (Figure <xref rid="dom12947-fig-0002" ref-type="fig">2</xref>A,B).<xref rid="dom12947-bib-0006" ref-type="ref">6</xref> Compared with participants with low BAT activity, those with high BAT activity had lower body adiposity and leptin concentration, greater whole&#x02010;body insulin sensitivity, and higher HDL cholesterol levels at baseline, suggesting a healthier metabolic phenotype (Table <xref rid="dom12947-tbl-0001" ref-type="table-wrap">1</xref>). Participants with high BAT activity also showed lower IL&#x02010;6 levels, but higher circulating MCP&#x02010;1 levels. During insulin stimulation, oxidation of carbohydrates was significantly higher in the high BAT than in the low BAT activity groups (Table <xref rid="dom12947-tbl-0002" ref-type="table-wrap">2</xref>), which is consistent with better M&#x02010;values. Despite the higher BAT glucose uptake, no difference was observed in BAT FFA uptake (Figure <xref rid="dom12947-fig-0002" ref-type="fig">2</xref>D), BAT mass, BAT radiodensity (Table <xref rid="dom12947-tbl-0001" ref-type="table-wrap">1</xref>), or quadriceps muscle glucose uptake (Figure <xref rid="dom12947-fig-0003" ref-type="fig">3</xref>A) between groups at baseline. By contrast, visceral adipose tissue glucose uptake was significantly higher (Figure <xref rid="dom12947-fig-0003" ref-type="fig">3</xref>B), and quadriceps muscle FFA uptake tended to be higher in the high BAT than the low BAT activity group (<italic>P</italic> = .06, Figure <xref rid="dom12947-fig-0003" ref-type="fig">3</xref>C).</p><fig fig-type="Figure" xml:lang="en" id="dom12947-fig-0002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>A, Division of subjects into high BAT (circles) and low BAT activity groups (triangles) with a threshold of 2.9 &#x000b5;mol/100 g/min at baseline. B, BAT insulin&#x02010;stimulated glucose uptake (GU) before (white bars) and after the exercise intervention (grey bars). C, Insulin&#x02010;stimulated BAT glucose uptake in each individual in the high BAT group before and after the exercise intervention. D, Fasting FFA uptake in high BAT and low BAT activity groups before and after the exercise intervention. E, Fasting FFA uptake in each individual in the low BAT activity group before and after the exercise intervention. ##<styled-content style="italic-in-any-context">P</styled-content> &#x0003c; .0001, #<styled-content style="italic-in-any-context">P</styled-content> = .03 difference between the groups at baseline, &#x02020;&#x02020;<styled-content style="italic-in-any-context">P</styled-content> = .01, &#x02020;<styled-content style="italic-in-any-context">P</styled-content> = .02 indicates whether high BAT and low BAT activity groups behaved differently for the change in variable, with significant difference between them (training*BAT)</p></caption><graphic id="nlm-graphic-3" xlink:href="DOM-19-1379-g001"/></fig><table-wrap id="dom12947-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label>Table 1</label><caption><p>Characteristics of high BAT and low BAT activity groups before (Pre) and after exercise training (Post)</p></caption><table frame="hsides" rules="groups"><col width="1*" align="left" span="1"/><col width="1*" align="left" span="1"/><col width="1*" align="left" span="1"/><col width="1*" align="left" span="1"/><col width="1*" align="left" span="1"/><col width="1*" align="left" span="1"/><col width="1*" align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th id="dom12947-ent-0001" style="border-bottom:solid 1px #000000" align="left" valign="bottom" rowspan="1" colspan="1"/><th colspan="2" id="dom12947-ent-0002" align="left" valign="bottom" rowspan="1">High BAT activity (n = 6)</th><th colspan="2" id="dom12947-ent-0003" align="left" valign="bottom" rowspan="1">Low BAT activity (n = 12)</th><th colspan="2" id="dom12947-ent-0004" align="left" valign="bottom" rowspan="1">
<italic>P</italic>
</th></tr><tr style="border-bottom:solid 1px #000000"><th id="dom12947-ent-0005" align="left" valign="bottom" rowspan="1" colspan="1"/><th id="dom12947-ent-0006" align="left" valign="bottom" rowspan="1" colspan="1">Pre</th><th id="dom12947-ent-0007" align="left" valign="bottom" rowspan="1" colspan="1">Post</th><th id="dom12947-ent-0008" align="left" valign="bottom" rowspan="1" colspan="1">Pre</th><th id="dom12947-ent-0009" align="left" valign="bottom" rowspan="1" colspan="1">Post</th><th id="dom12947-ent-0010" align="left" valign="bottom" rowspan="1" colspan="1">Training</th><th id="dom12947-ent-0011" align="left" valign="bottom" rowspan="1" colspan="1">Training*BAT</th></tr></thead><tbody valign="top"><tr><td id="dom12947-ent-0012" align="left" valign="top" rowspan="1" colspan="1">Anthropometrics</td><td id="dom12947-ent-0013" align="left" valign="top" rowspan="1" colspan="1"/><td id="dom12947-ent-0014" align="left" valign="top" rowspan="1" colspan="1"/><td id="dom12947-ent-0015" align="left" valign="top" rowspan="1" colspan="1"/><td id="dom12947-ent-0016" align="left" valign="top" rowspan="1" colspan="1"/><td id="dom12947-ent-0017" align="left" valign="top" rowspan="1" colspan="1"/><td id="dom12947-ent-0018" align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td id="dom12947-ent-0019" align="left" valign="top" rowspan="1" colspan="1">Body mass index, kg/m<sup>2</sup>
</td><td align="left" id="dom12947-ent-0020" valign="top" rowspan="1" colspan="1">23.6 (22, 25)#</td><td align="left" id="dom12947-ent-0021" valign="top" rowspan="1" colspan="1">23.7(22, 26)#</td><td align="left" id="dom12947-ent-0022" valign="top" rowspan="1" colspan="1">26.9 (26, 28)</td><td align="left" id="dom12947-ent-0023" valign="top" rowspan="1" colspan="1">26.8 (26, 28)</td><td align="left" id="dom12947-ent-0024" valign="top" rowspan="1" colspan="1">.93</td><td align="left" id="dom12947-ent-0025" valign="top" rowspan="1" colspan="1">.75</td></tr><tr><td id="dom12947-ent-0026" align="left" valign="top" rowspan="1" colspan="1">Fat percentage</td><td align="left" id="dom12947-ent-0027" valign="top" rowspan="1" colspan="1">18.7 (15, 23)#</td><td align="left" id="dom12947-ent-0028" valign="top" rowspan="1" colspan="1">17.6 (14, 22)</td><td align="left" id="dom12947-ent-0029" valign="top" rowspan="1" colspan="1">24.1 (21, 26)</td><td align="left" id="dom12947-ent-0030" valign="top" rowspan="1" colspan="1">23.7 (21, 26)</td><td align="left" id="dom12947-ent-0031" valign="top" rowspan="1" colspan="1">
<bold>.04</bold>
</td><td align="left" id="dom12947-ent-0032" valign="top" rowspan="1" colspan="1">.37</td></tr><tr><td id="dom12947-ent-0033" align="left" valign="top" rowspan="1" colspan="1">Waist, cm</td><td align="left" id="dom12947-ent-0034" valign="top" rowspan="1" colspan="1">87.1 (81, 93)#</td><td align="left" id="dom12947-ent-0035" valign="top" rowspan="1" colspan="1">86.3 (80, 93)#</td><td align="left" id="dom12947-ent-0036" valign="top" rowspan="1" colspan="1">98.7 (94, 103)</td><td align="left" id="dom12947-ent-0037" valign="top" rowspan="1" colspan="1">98.1 (94, 102)</td><td align="left" id="dom12947-ent-0038" valign="top" rowspan="1" colspan="1">.08</td><td align="left" id="dom12947-ent-0039" valign="top" rowspan="1" colspan="1">.68</td></tr><tr><td id="dom12947-ent-0040" align="left" valign="top" rowspan="1" colspan="1">VO<sub>2peak</sub> , mL/kg/min</td><td align="left" id="dom12947-ent-0041" valign="top" rowspan="1" colspan="1">36.1 (32, 41)</td><td align="left" id="dom12947-ent-0042" valign="top" rowspan="1" colspan="1">39.1 (35, 44)</td><td align="left" id="dom12947-ent-0043" valign="top" rowspan="1" colspan="1">33.4 (31, 36)</td><td align="left" id="dom12947-ent-0044" valign="top" rowspan="1" colspan="1">34.9 (32, 38)</td><td align="left" id="dom12947-ent-0045" valign="top" rowspan="1" colspan="1">
<bold>.0005</bold>
</td><td align="left" id="dom12947-ent-0046" valign="top" rowspan="1" colspan="1">.16</td></tr><tr><td id="dom12947-ent-0047" align="left" valign="top" rowspan="1" colspan="1">Systolic blood pressure, mm Hg</td><td align="left" id="dom12947-ent-0048" valign="top" rowspan="1" colspan="1">120 (113, 127)</td><td align="left" id="dom12947-ent-0049" valign="top" rowspan="1" colspan="1">122 (116, 129)#</td><td align="left" id="dom12947-ent-0050" valign="top" rowspan="1" colspan="1">127 (122, 133)</td><td align="left" id="dom12947-ent-0051" valign="top" rowspan="1" colspan="1">131 (127, 135)</td><td align="left" id="dom12947-ent-0052" valign="top" rowspan="1" colspan="1">.13</td><td align="left" id="dom12947-ent-0053" valign="top" rowspan="1" colspan="1">.61</td></tr><tr><td id="dom12947-ent-0054" align="left" valign="top" rowspan="1" colspan="1">Diastolic blood pressure, mm Hg</td><td align="left" id="dom12947-ent-0055" valign="top" rowspan="1" colspan="1">77 (71, 83)</td><td align="left" id="dom12947-ent-0056" valign="top" rowspan="1" colspan="1">76 (69, 81)</td><td align="left" id="dom12947-ent-0057" valign="top" rowspan="1" colspan="1">77 (73, 81)</td><td align="left" id="dom12947-ent-0058" valign="top" rowspan="1" colspan="1">78 (74, 82)</td><td align="left" id="dom12947-ent-0059" valign="top" rowspan="1" colspan="1">.80</td><td align="left" id="dom12947-ent-0060" valign="top" rowspan="1" colspan="1">.53</td></tr><tr><td id="dom12947-ent-0061" align="left" valign="top" rowspan="1" colspan="1">Subcutaneous fat mass, kg</td><td align="left" id="dom12947-ent-0062" valign="top" rowspan="1" colspan="1">3.3 (1.9, 4.6)(#)</td><td align="left" id="dom12947-ent-0063" valign="top" rowspan="1" colspan="1">3.2 (1.9, 4.5)</td><td align="left" id="dom12947-ent-0064" valign="top" rowspan="1" colspan="1">4.8 (3.9, 5.7)</td><td align="left" id="dom12947-ent-0065" valign="top" rowspan="1" colspan="1">4.7 (3.8, 5.6)</td><td align="left" id="dom12947-ent-0066" valign="top" rowspan="1" colspan="1">.15</td><td align="left" id="dom12947-ent-0067" valign="top" rowspan="1" colspan="1">.85</td></tr><tr><td id="dom12947-ent-0068" align="left" valign="top" rowspan="1" colspan="1">Visceral fat mass, kg</td><td align="left" id="dom12947-ent-0069" valign="top" rowspan="1" colspan="1">
<xref ref-type="fn" rid="dom12947-note-0006">a</xref>1.2 (0.7, 2.1)#</td><td align="left" id="dom12947-ent-0070" valign="top" rowspan="1" colspan="1">1.1 (0.6, 1.1)</td><td align="left" id="dom12947-ent-0071" valign="top" rowspan="1" colspan="1">3.0 (2.0, 4.3)</td><td align="left" id="dom12947-ent-0072" valign="top" rowspan="1" colspan="1">2.8 (1.9, 4.1)</td><td align="left" id="dom12947-ent-0073" valign="top" rowspan="1" colspan="1">
<bold>.009</bold>
</td><td align="left" id="dom12947-ent-0074" valign="top" rowspan="1" colspan="1">.30</td></tr><tr><td id="dom12947-ent-0075" align="left" valign="top" rowspan="1" colspan="1">Glucose profile</td><td id="dom12947-ent-0076" align="left" valign="top" rowspan="1" colspan="1"/><td id="dom12947-ent-0077" align="left" valign="top" rowspan="1" colspan="1"/><td id="dom12947-ent-0078" align="left" valign="top" rowspan="1" colspan="1"/><td id="dom12947-ent-0079" align="left" valign="top" rowspan="1" colspan="1"/><td id="dom12947-ent-0080" align="left" valign="top" rowspan="1" colspan="1"/><td id="dom12947-ent-0081" align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td id="dom12947-ent-0082" align="left" valign="top" rowspan="1" colspan="1">M value</td><td align="left" id="dom12947-ent-0083" valign="top" rowspan="1" colspan="1">48.9 (36, 62)#</td><td align="left" id="dom12947-ent-0084" valign="top" rowspan="1" colspan="1">49.3 (36, 62)</td><td align="left" id="dom12947-ent-0085" valign="top" rowspan="1" colspan="1">31.1 (22, 40)</td><td align="left" id="dom12947-ent-0086" valign="top" rowspan="1" colspan="1">36.8 (28, 46)</td><td align="left" id="dom12947-ent-0087" valign="top" rowspan="1" colspan="1">.13</td><td align="left" id="dom12947-ent-0088" valign="top" rowspan="1" colspan="1">.18</td></tr><tr><td id="dom12947-ent-0089" align="left" valign="top" rowspan="1" colspan="1">Glucose<sub>fasting</sub>, mmol/L</td><td align="left" id="dom12947-ent-0090" valign="top" rowspan="1" colspan="1">5.3 (5.1, 5.6)</td><td align="left" id="dom12947-ent-0091" valign="top" rowspan="1" colspan="1">5.8 (5.4, 6.2)</td><td align="left" id="dom12947-ent-0092" valign="top" rowspan="1" colspan="1">5.5 (5.3, 5.7)</td><td align="left" id="dom12947-ent-0093" valign="top" rowspan="1" colspan="1">5.7 (5.5, 5.9)</td><td align="left" id="dom12947-ent-0094" valign="top" rowspan="1" colspan="1">.05</td><td align="left" id="dom12947-ent-0095" valign="top" rowspan="1" colspan="1">.34</td></tr><tr><td id="dom12947-ent-0096" align="left" valign="top" rowspan="1" colspan="1">Glucose<sub>clamp</sub>, mmol/L</td><td align="left" id="dom12947-ent-0097" valign="top" rowspan="1" colspan="1">5.1 (4.5, 5.7)</td><td align="left" id="dom12947-ent-0098" valign="top" rowspan="1" colspan="1">5.3 (4.8, 5.8)</td><td align="left" id="dom12947-ent-0099" valign="top" rowspan="1" colspan="1">5.5 (5.3, 5.8)</td><td align="left" id="dom12947-ent-0100" valign="top" rowspan="1" colspan="1">5.5 (5.2, 5.7)</td><td align="left" id="dom12947-ent-0101" valign="top" rowspan="1" colspan="1">.47</td><td align="left" id="dom12947-ent-0102" valign="top" rowspan="1" colspan="1">.35</td></tr><tr><td id="dom12947-ent-0103" align="left" valign="top" rowspan="1" colspan="1">Insulin<sub>fasting</sub>, mmol/L</td><td align="left" id="dom12947-ent-0104" valign="top" rowspan="1" colspan="1">
<xref ref-type="fn" rid="dom12947-note-0006">a</xref>3.6 (2.5, 5.4)#</td><td align="left" id="dom12947-ent-0105" valign="top" rowspan="1" colspan="1">3.9 (2.7, 5.8)</td><td align="left" id="dom12947-ent-0106" valign="top" rowspan="1" colspan="1">5.7 (4.4, 7.4)</td><td align="left" id="dom12947-ent-0107" valign="top" rowspan="1" colspan="1">5.7 (4.4, 7.5)</td><td align="left" id="dom12947-ent-0108" valign="top" rowspan="1" colspan="1">.54</td><td align="left" id="dom12947-ent-0109" valign="top" rowspan="1" colspan="1">.62</td></tr><tr><td id="dom12947-ent-0110" align="left" valign="top" rowspan="1" colspan="1">Insulin<sub>clamp</sub>, mmol/L</td><td align="left" id="dom12947-ent-0111" valign="top" rowspan="1" colspan="1">79.5 (64, 95)</td><td align="left" id="dom12947-ent-0112" valign="top" rowspan="1" colspan="1">81.7(66, 98)</td><td align="left" id="dom12947-ent-0113" valign="top" rowspan="1" colspan="1">72.3 (62, 83)</td><td align="left" id="dom12947-ent-0114" valign="top" rowspan="1" colspan="1">74.3 (64, 85)</td><td align="left" id="dom12947-ent-0115" valign="top" rowspan="1" colspan="1">.59</td><td align="left" id="dom12947-ent-0116" valign="top" rowspan="1" colspan="1">.99</td></tr><tr><td id="dom12947-ent-0117" align="left" valign="top" rowspan="1" colspan="1">HbA1c, %</td><td align="left" id="dom12947-ent-0118" valign="top" rowspan="1" colspan="1">5.3 (5.0, 5.6) </td><td align="left" id="dom12947-ent-0119" valign="top" rowspan="1" colspan="1">5.1 (4.8, 5.4)</td><td align="left" id="dom12947-ent-0120" valign="top" rowspan="1" colspan="1">5.7 (5.5, 5.9)</td><td align="left" id="dom12947-ent-0121" valign="top" rowspan="1" colspan="1">5.4 (5.2, 5.6)</td><td align="left" id="dom12947-ent-0122" valign="top" rowspan="1" colspan="1">
<bold>.003</bold>
</td><td align="left" id="dom12947-ent-0123" valign="top" rowspan="1" colspan="1">.70</td></tr><tr><td id="dom12947-ent-0124" align="left" valign="top" rowspan="1" colspan="1">Lipid profile</td><td id="dom12947-ent-0125" align="left" valign="top" rowspan="1" colspan="1"/><td id="dom12947-ent-0126" align="left" valign="top" rowspan="1" colspan="1"/><td id="dom12947-ent-0127" align="left" valign="top" rowspan="1" colspan="1"/><td id="dom12947-ent-0128" align="left" valign="top" rowspan="1" colspan="1"/><td id="dom12947-ent-0129" align="left" valign="top" rowspan="1" colspan="1"/><td id="dom12947-ent-0130" align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td id="dom12947-ent-0131" align="left" valign="top" rowspan="1" colspan="1">FFA<sub>fasting</sub>
</td><td align="left" id="dom12947-ent-0132" valign="top" rowspan="1" colspan="1">0.82 (0.5, 1.1)</td><td align="left" id="dom12947-ent-0133" valign="top" rowspan="1" colspan="1">0.91 (0.6, 1.2)</td><td align="left" id="dom12947-ent-0134" valign="top" rowspan="1" colspan="1">0.65 (0.4, 0.9)</td><td align="left" id="dom12947-ent-0135" valign="top" rowspan="1" colspan="1">0.61 (0.4, 0.8)</td><td align="left" id="dom12947-ent-0136" valign="top" rowspan="1" colspan="1">.80</td><td align="left" id="dom12947-ent-0137" valign="top" rowspan="1" colspan="1">.47</td></tr><tr><td id="dom12947-ent-0138" align="left" valign="top" rowspan="1" colspan="1">FFA<sub>clamp</sub>
</td><td align="left" id="dom12947-ent-0139" valign="top" rowspan="1" colspan="1">0.46 (0.3, 0.6)</td><td align="left" id="dom12947-ent-0140" valign="top" rowspan="1" colspan="1">0.51 (0.4, 0.7)</td><td align="left" id="dom12947-ent-0141" valign="top" rowspan="1" colspan="1">0.41 (0.3, 0.5)</td><td align="left" id="dom12947-ent-0142" valign="top" rowspan="1" colspan="1">0.37 (0.3, 0.5)</td><td align="left" id="dom12947-ent-0143" valign="top" rowspan="1" colspan="1">.93</td><td align="left" id="dom12947-ent-0144" valign="top" rowspan="1" colspan="1">.38</td></tr><tr><td id="dom12947-ent-0145" align="left" valign="top" rowspan="1" colspan="1">Cholesterol, mmol/L</td><td align="left" id="dom12947-ent-0146" valign="top" rowspan="1" colspan="1">4.85 (4.0, 5.7)</td><td align="left" id="dom12947-ent-0147" valign="top" rowspan="1" colspan="1">4.24 (3.4, 5.1)</td><td align="left" id="dom12947-ent-0148" valign="top" rowspan="1" colspan="1">5.09 (4.5, 5.7)</td><td align="left" id="dom12947-ent-0149" valign="top" rowspan="1" colspan="1">4.61 (4.0, 5.2)</td><td align="left" id="dom12947-ent-0150" valign="top" rowspan="1" colspan="1">
<bold>.002</bold>
</td><td align="left" id="dom12947-ent-0151" valign="top" rowspan="1" colspan="1">.66</td></tr><tr><td id="dom12947-ent-0152" align="left" valign="top" rowspan="1" colspan="1">LDL cholesterol, mmol/L</td><td align="left" id="dom12947-ent-0153" valign="top" rowspan="1" colspan="1">2.90 (2.2, 3.6)</td><td align="left" id="dom12947-ent-0154" valign="top" rowspan="1" colspan="1">2.46 (1.7, 3.2)</td><td align="left" id="dom12947-ent-0155" valign="top" rowspan="1" colspan="1">3.40 (2.9, 3.9)</td><td align="left" id="dom12947-ent-0156" valign="top" rowspan="1" colspan="1">3.03 (2.5, 3.5)</td><td align="left" id="dom12947-ent-0157" valign="top" rowspan="1" colspan="1">
<bold>.004</bold>
</td><td align="left" id="dom12947-ent-0158" valign="top" rowspan="1" colspan="1">.77</td></tr><tr><td id="dom12947-ent-0159" align="left" valign="top" rowspan="1" colspan="1">HDL cholesterol, mmol/L</td><td align="left" id="dom12947-ent-0160" valign="top" rowspan="1" colspan="1">
<xref ref-type="fn" rid="dom12947-note-0006">a</xref>1.57 (1.4,1.8)##</td><td align="left" id="dom12947-ent-0161" valign="top" rowspan="1" colspan="1">1.50 (1.3, 1.7)<bold>#</bold>
</td><td align="left" id="dom12947-ent-0162" valign="top" rowspan="1" colspan="1">1.17 (1.1, 1.3)</td><td align="left" id="dom12947-ent-0163" valign="top" rowspan="1" colspan="1">1.12 (1.0, 1.2)</td><td align="left" id="dom12947-ent-0164" valign="top" rowspan="1" colspan="1">.27</td><td align="left" id="dom12947-ent-0165" valign="top" rowspan="1" colspan="1">.99</td></tr><tr><td id="dom12947-ent-0166" align="left" valign="top" rowspan="1" colspan="1">Triglycerides, mmol/L</td><td align="left" id="dom12947-ent-0167" valign="top" rowspan="1" colspan="1">0.80 (0.5, 1.1)</td><td align="left" id="dom12947-ent-0168" valign="top" rowspan="1" colspan="1">0.59 (0.3, 0.9)<bold>#</bold>
</td><td align="left" id="dom12947-ent-0169" valign="top" rowspan="1" colspan="1">1.10 (0.9, 1.3)</td><td align="left" id="dom12947-ent-0170" valign="top" rowspan="1" colspan="1">1.00 (0.8, 1.2)</td><td align="left" id="dom12947-ent-0171" valign="top" rowspan="1" colspan="1">.08</td><td align="left" id="dom12947-ent-0172" valign="top" rowspan="1" colspan="1">.51</td></tr><tr><td id="dom12947-ent-0173" align="left" valign="top" rowspan="1" colspan="1">Others</td><td id="dom12947-ent-0174" align="left" valign="top" rowspan="1" colspan="1"/><td id="dom12947-ent-0175" align="left" valign="top" rowspan="1" colspan="1"/><td id="dom12947-ent-0176" align="left" valign="top" rowspan="1" colspan="1"/><td id="dom12947-ent-0177" align="left" valign="top" rowspan="1" colspan="1"/><td id="dom12947-ent-0178" align="left" valign="top" rowspan="1" colspan="1"/><td id="dom12947-ent-0179" align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td id="dom12947-ent-0180" align="left" valign="top" rowspan="1" colspan="1">Epinephrine</td><td align="left" id="dom12947-ent-0181" valign="top" rowspan="1" colspan="1">
<xref ref-type="fn" rid="dom12947-note-0006">a</xref>0.14 (0.09, 0.23)</td><td align="left" id="dom12947-ent-0182" valign="top" rowspan="1" colspan="1">0.17 (0.11, 0.27)</td><td align="left" id="dom12947-ent-0183" valign="top" rowspan="1" colspan="1">0.14 (0.10, 0.19)</td><td align="left" id="dom12947-ent-0184" valign="top" rowspan="1" colspan="1">0.25 (0.18, 0.34)</td><td align="left" id="dom12947-ent-0185" valign="top" rowspan="1" colspan="1">
<bold>.02</bold>
</td><td align="left" id="dom12947-ent-0186" valign="top" rowspan="1" colspan="1">.19</td></tr><tr><td id="dom12947-ent-0187" align="left" valign="top" rowspan="1" colspan="1">Norepinephrine</td><td align="left" id="dom12947-ent-0188" valign="top" rowspan="1" colspan="1">
<xref ref-type="fn" rid="dom12947-note-0006">a</xref>1.67 (1.2, 2.2)</td><td align="left" id="dom12947-ent-0189" valign="top" rowspan="1" colspan="1">2.09 (1.6, 2.8)</td><td align="left" id="dom12947-ent-0190" valign="top" rowspan="1" colspan="1">1.95 (1.6, 2.4)</td><td align="left" id="dom12947-ent-0191" valign="top" rowspan="1" colspan="1">2.17 (1.8, 2.6)</td><td align="left" id="dom12947-ent-0192" valign="top" rowspan="1" colspan="1">.13</td><td align="left" id="dom12947-ent-0193" valign="top" rowspan="1" colspan="1">.57</td></tr><tr><td id="dom12947-ent-0194" align="left" valign="top" rowspan="1" colspan="1">NGF, pmol/L</td><td align="left" id="dom12947-ent-0195" valign="top" rowspan="1" colspan="1">
<xref ref-type="fn" rid="dom12947-note-0006">a</xref>0.02 (0.01, 0.06)</td><td align="left" id="dom12947-ent-0196" valign="top" rowspan="1" colspan="1">0.01 (0.01, 0.05)</td><td align="left" id="dom12947-ent-0197" valign="top" rowspan="1" colspan="1">0.04 (0.02, 0.07)</td><td align="left" id="dom12947-ent-0198" valign="top" rowspan="1" colspan="1">0.05 (0.03, 0.09)</td><td align="left" id="dom12947-ent-0199" valign="top" rowspan="1" colspan="1">.95</td><td align="left" id="dom12947-ent-0200" valign="top" rowspan="1" colspan="1">.37</td></tr><tr><td id="dom12947-ent-0201" align="left" valign="top" rowspan="1" colspan="1">IL&#x02010;6, pmol/L</td><td align="left" id="dom12947-ent-0202" valign="top" rowspan="1" colspan="1">
<xref ref-type="fn" rid="dom12947-note-0006">a</xref>0.01 (0.002, 0.04)#</td><td align="left" id="dom12947-ent-0203" valign="top" rowspan="1" colspan="1">0.01 (0.02, 0.06)</td><td align="left" id="dom12947-ent-0204" valign="top" rowspan="1" colspan="1">0.06 (0.02, 0.14)</td><td align="left" id="dom12947-ent-0205" valign="top" rowspan="1" colspan="1">0.02 (0.01, 0.04)</td><td align="left" id="dom12947-ent-0206" valign="top" rowspan="1" colspan="1">.27</td><td align="left" id="dom12947-ent-0207" valign="top" rowspan="1" colspan="1">
<bold>.04</bold>
</td></tr><tr><td id="dom12947-ent-0208" align="left" valign="top" rowspan="1" colspan="1">IL&#x02010;8, pmol/L</td><td align="left" id="dom12947-ent-0209" valign="top" rowspan="1" colspan="1">0.44 (0.2, 0.6)</td><td align="left" id="dom12947-ent-0210" valign="top" rowspan="1" colspan="1">0.40 (0.2, 0.6)</td><td align="left" id="dom12947-ent-0211" valign="top" rowspan="1" colspan="1">0.58 (0.5, 0.7)</td><td align="left" id="dom12947-ent-0212" valign="top" rowspan="1" colspan="1">0.55 (0.4, 0.7)</td><td align="left" id="dom12947-ent-0213" valign="top" rowspan="1" colspan="1">.48</td><td align="left" id="dom12947-ent-0214" valign="top" rowspan="1" colspan="1">.87</td></tr><tr><td id="dom12947-ent-0215" align="left" valign="top" rowspan="1" colspan="1">Leptin, pmol/L</td><td align="left" id="dom12947-ent-0216" valign="top" rowspan="1" colspan="1">87 (58, 232)<sup>#</sup>
</td><td align="left" id="dom12947-ent-0217" valign="top" rowspan="1" colspan="1">95 (61, 252)</td><td align="left" id="dom12947-ent-0218" valign="top" rowspan="1" colspan="1">276 (189, 363)</td><td align="left" id="dom12947-ent-0219" valign="top" rowspan="1" colspan="1">235 (150, 320)</td><td align="left" id="dom12947-ent-0220" valign="top" rowspan="1" colspan="1">.59</td><td align="left" id="dom12947-ent-0221" valign="top" rowspan="1" colspan="1">.43</td></tr><tr><td id="dom12947-ent-0222" align="left" valign="top" rowspan="1" colspan="1">HGF, pmol/L</td><td align="left" id="dom12947-ent-0223" valign="top" rowspan="1" colspan="1">4.2 (1.5, 6.8)</td><td align="left" id="dom12947-ent-0224" valign="top" rowspan="1" colspan="1">3.8 (0.9, 6.6)</td><td align="left" id="dom12947-ent-0225" valign="top" rowspan="1" colspan="1">5.3 (3.8, 6.9)</td><td align="left" id="dom12947-ent-0226" valign="top" rowspan="1" colspan="1">4.3 (2.7, 5.8)</td><td align="left" id="dom12947-ent-0227" valign="top" rowspan="1" colspan="1">.17</td><td align="left" id="dom12947-ent-0228" valign="top" rowspan="1" colspan="1">.55</td></tr><tr><td id="dom12947-ent-0229" align="left" valign="top" rowspan="1" colspan="1">MCP&#x02010;1, pmol/L</td><td align="left" id="dom12947-ent-0230" valign="top" rowspan="1" colspan="1">22.0 (16, 28)#</td><td align="left" id="dom12947-ent-0231" valign="top" rowspan="1" colspan="1">23.1 (17, 30)</td><td align="left" id="dom12947-ent-0232" valign="top" rowspan="1" colspan="1">15.5 (12, 19)</td><td align="left" id="dom12947-ent-0233" valign="top" rowspan="1" colspan="1">16.6 (13, 20)</td><td align="left" id="dom12947-ent-0234" valign="top" rowspan="1" colspan="1">.20</td><td align="left" id="dom12947-ent-0235" valign="top" rowspan="1" colspan="1">.99</td></tr><tr><td id="dom12947-ent-0236" align="left" valign="top" rowspan="1" colspan="1">TNF&#x02010;&#x003b1;, pmol/L</td><td align="left" id="dom12947-ent-0237" valign="top" rowspan="1" colspan="1">
<xref ref-type="fn" rid="dom12947-note-0006">a</xref>0.16 (0.1, 0.3)</td><td align="left" id="dom12947-ent-0238" valign="top" rowspan="1" colspan="1">0.15 (0.1, 0.3)</td><td align="left" id="dom12947-ent-0239" valign="top" rowspan="1" colspan="1">0.29 (0.2, 0.4)</td><td align="left" id="dom12947-ent-0240" valign="top" rowspan="1" colspan="1">0.25 (0.2, 0.3)</td><td align="left" id="dom12947-ent-0241" valign="top" rowspan="1" colspan="1">.27</td><td align="left" id="dom12947-ent-0242" valign="top" rowspan="1" colspan="1">.53</td></tr><tr><td id="dom12947-ent-0243" align="left" valign="top" rowspan="1" colspan="1">BAT mass (g)</td><td align="left" id="dom12947-ent-0244" valign="top" rowspan="1" colspan="1">
<xref ref-type="fn" rid="dom12947-note-0006">a</xref>80.1 (43, 148)</td><td align="left" id="dom12947-ent-0245" valign="top" rowspan="1" colspan="1">81.5 (42, 157)</td><td align="left" id="dom12947-ent-0246" valign="top" rowspan="1" colspan="1">64.9 (43, 98)</td><td align="left" id="dom12947-ent-0247" valign="top" rowspan="1" colspan="1">61.8 (41, 94)</td><td align="left" id="dom12947-ent-0248" valign="top" rowspan="1" colspan="1">.95</td><td align="left" id="dom12947-ent-0249" valign="top" rowspan="1" colspan="1">.89</td></tr><tr><td id="dom12947-ent-0250" align="left" valign="top" rowspan="1" colspan="1">BAT radiodensity (CT HU)</td><td id="dom12947-ent-0251" align="left" valign="top" rowspan="1" colspan="1">&#x02212;87.5 (&#x02212;93, &#x02212;82)</td><td id="dom12947-ent-0252" align="left" valign="top" rowspan="1" colspan="1">&#x02212;88.4 (&#x02212;94, &#x02212;83)</td><td id="dom12947-ent-0253" align="left" valign="top" rowspan="1" colspan="1">&#x02212;91.6 (&#x02212;95, &#x02212;88)</td><td id="dom12947-ent-0254" align="left" valign="top" rowspan="1" colspan="1">&#x02212;91.0 (&#x02212;95, &#x02212;87)</td><td align="left" id="dom12947-ent-0255" valign="top" rowspan="1" colspan="1">.93</td><td align="left" id="dom12947-ent-0256" valign="top" rowspan="1" colspan="1">.58</td></tr></tbody></table><table-wrap-foot><fn id="dom12947-note-0004"><p>Abbreviation: HbA1c, glycated haemoglobin.</p></fn><fn id="dom12947-note-0005"><p>Values are means and 95% CIs.</p></fn><fn id="dom12947-note-0006"><label>a</label><p>Log transformation was done to achieve normal distribution.</p></fn><fn id="dom12947-note-0007"><p>#<styled-content style="italic-in-any-context">P</styled-content> &#x0003c; .05, ##<styled-content style="italic-in-any-context">P</styled-content> &#x0003c; .01 and (#)<styled-content style="italic-in-any-context">P</styled-content> = .052 significant difference between groups in corresponding time point. <styled-content style="italic-in-any-context">P</styled-content> value (training) indicates the mean changes in before (pre) and post intervention measurements in the whole group, <styled-content style="italic-in-any-context">P</styled-content>&#x02010;value (training*BAT) indicates whether high BAT and low BAT activity groups behaved differently for the change in variable with significant difference between them.Statistically significant values <styled-content style="italic-in-any-context">P</styled-content> &#x0003c; .05 are marked as bold.</p></fn></table-wrap-foot></table-wrap><table-wrap id="dom12947-tbl-0002" xml:lang="en" orientation="portrait" position="float"><label>Table 2</label><caption><p>Energy expenditure of high BAT and low BAT groups when fasting and during hyperinsulinaemia</p></caption><table frame="hsides" rules="groups"><col width="1*" align="left" span="1"/><col width="1*" align="left" span="1"/><col width="1*" align="left" span="1"/><col width="1*" align="left" span="1"/><col width="1*" align="left" span="1"/><col width="1*" align="left" span="1"/><col width="1*" align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th id="dom12947-ent-0257" style="border-bottom:solid 1px #000000" align="left" valign="bottom" rowspan="1" colspan="1"/><th colspan="2" id="dom12947-ent-0258" align="left" valign="bottom" rowspan="1">High BAT (n = 6)</th><th colspan="2" id="dom12947-ent-0259" align="left" valign="bottom" rowspan="1">Low BAT (n = 12)</th><th colspan="2" id="dom12947-ent-0260" align="left" valign="bottom" rowspan="1">
<italic>P</italic>
</th></tr><tr style="border-bottom:solid 1px #000000"><th id="dom12947-ent-0261" align="left" valign="bottom" rowspan="1" colspan="1"/><th id="dom12947-ent-0262" align="left" valign="bottom" rowspan="1" colspan="1">Pre</th><th id="dom12947-ent-0263" align="left" valign="bottom" rowspan="1" colspan="1">Post</th><th id="dom12947-ent-0264" align="left" valign="bottom" rowspan="1" colspan="1">Pre</th><th id="dom12947-ent-0265" align="left" valign="bottom" rowspan="1" colspan="1">Post</th><th id="dom12947-ent-0266" align="left" valign="bottom" rowspan="1" colspan="1">Training</th><th id="dom12947-ent-0267" align="left" valign="bottom" rowspan="1" colspan="1">Training*BAT</th></tr></thead><tbody valign="top"><tr><td id="dom12947-ent-0268" align="left" valign="top" rowspan="1" colspan="1">Energy oxidation</td><td id="dom12947-ent-0269" align="left" valign="top" rowspan="1" colspan="1"/><td id="dom12947-ent-0270" align="left" valign="top" rowspan="1" colspan="1"/><td id="dom12947-ent-0271" align="left" valign="top" rowspan="1" colspan="1"/><td id="dom12947-ent-0272" align="left" valign="top" rowspan="1" colspan="1"/><td id="dom12947-ent-0273" align="left" valign="top" rowspan="1" colspan="1"/><td id="dom12947-ent-0274" align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td id="dom12947-ent-0275" align="left" valign="top" rowspan="1" colspan="1">Adj REE<sub>fasting</sub>, MJ/d</td><td id="dom12947-ent-0276" align="left" valign="top" rowspan="1" colspan="1">
<xref ref-type="fn" rid="dom12947-note-0010">a</xref>6.62 (6.1, 7.2)</td><td id="dom12947-ent-0277" align="left" valign="top" rowspan="1" colspan="1">6.62 (6.1, 7.2)#</td><td id="dom12947-ent-0278" align="left" valign="top" rowspan="1" colspan="1">6.81 (6.4, 7.2)</td><td id="dom12947-ent-0279" align="left" valign="top" rowspan="1" colspan="1">6.86 (6.5, 7.3)</td><td align="left" id="dom12947-ent-0280" valign="top" rowspan="1" colspan="1">.88</td><td align="left" id="dom12947-ent-0281" valign="top" rowspan="1" colspan="1">.88</td></tr><tr><td id="dom12947-ent-0282" align="left" valign="top" rowspan="1" colspan="1">Adj REE<sub>clamp</sub>, MJ/d</td><td id="dom12947-ent-0283" align="left" valign="top" rowspan="1" colspan="1">
<xref ref-type="fn" rid="dom12947-note-0010">a</xref>7.09 (6.6, 7.6)</td><td id="dom12947-ent-0284" align="left" valign="top" rowspan="1" colspan="1">6.99 (6.5, 7.5)</td><td id="dom12947-ent-0285" align="left" valign="top" rowspan="1" colspan="1">7.19 (6.8, 7.6)</td><td id="dom12947-ent-0286" align="left" valign="top" rowspan="1" colspan="1">7.15 (6.8, 7.5)</td><td align="left" id="dom12947-ent-0287" valign="top" rowspan="1" colspan="1">.58</td><td align="left" id="dom12947-ent-0288" valign="top" rowspan="1" colspan="1">.85</td></tr><tr><td id="dom12947-ent-0289" align="left" valign="top" rowspan="1" colspan="1">Carbohydrate<sub>fasting</sub>, g/min</td><td id="dom12947-ent-0290" align="left" valign="top" rowspan="1" colspan="1">2.27 (1.6, 3.0)</td><td id="dom12947-ent-0291" align="left" valign="top" rowspan="1" colspan="1">1.80 (1.1, 2.5)</td><td id="dom12947-ent-0292" align="left" valign="top" rowspan="1" colspan="1">2.18 (1.7, 2.7)</td><td id="dom12947-ent-0293" align="left" valign="top" rowspan="1" colspan="1">2.32 (1.8, 2.9)</td><td align="left" id="dom12947-ent-0294" valign="top" rowspan="1" colspan="1">.58</td><td align="left" id="dom12947-ent-0295" valign="top" rowspan="1" colspan="1">.32</td></tr><tr><td id="dom12947-ent-0296" align="left" valign="top" rowspan="1" colspan="1">Carbohydrate<sub>clamp</sub>, g/min</td><td id="dom12947-ent-0297" align="left" valign="top" rowspan="1" colspan="1">3.66 (2.9, 4.4)#</td><td id="dom12947-ent-0298" align="left" valign="top" rowspan="1" colspan="1">3.08 (2.3, 3.8)</td><td id="dom12947-ent-0299" align="left" valign="top" rowspan="1" colspan="1">2.86 (2.3, 3.4)</td><td id="dom12947-ent-0300" align="left" valign="top" rowspan="1" colspan="1">2.91 (2.3, 3.4)</td><td align="left" id="dom12947-ent-0301" valign="top" rowspan="1" colspan="1">.34</td><td align="left" id="dom12947-ent-0302" valign="top" rowspan="1" colspan="1">.26</td></tr><tr><td id="dom12947-ent-0303" align="left" valign="top" rowspan="1" colspan="1">Fat<sub>fasting</sub>, g/min</td><td id="dom12947-ent-0304" align="left" valign="top" rowspan="1" colspan="1">2.33 (1.6, 3.0)</td><td id="dom12947-ent-0305" align="left" valign="top" rowspan="1" colspan="1">2.82 (2.1, 3.5)</td><td id="dom12947-ent-0306" align="left" valign="top" rowspan="1" colspan="1">2.65 (2.1, 3.2)</td><td id="dom12947-ent-0307" align="left" valign="top" rowspan="1" colspan="1">2.82 (2.0, 3.1)</td><td align="left" id="dom12947-ent-0308" valign="top" rowspan="1" colspan="1">.54</td><td align="left" id="dom12947-ent-0309" valign="top" rowspan="1" colspan="1">.34</td></tr><tr><td id="dom12947-ent-0310" align="left" valign="top" rowspan="1" colspan="1">Fat<sub>clamp</sub>, g/min</td><td id="dom12947-ent-0311" align="left" valign="top" rowspan="1" colspan="1">0.98 (0.2, 1.7)#</td><td id="dom12947-ent-0312" align="left" valign="top" rowspan="1" colspan="1">1.51 (0.8, 2.2)</td><td id="dom12947-ent-0313" align="left" valign="top" rowspan="1" colspan="1">2.36 (1.8, 2.9)</td><td id="dom12947-ent-0314" align="left" valign="top" rowspan="1" colspan="1">2.22 (1.7, 2.7)</td><td align="left" id="dom12947-ent-0315" valign="top" rowspan="1" colspan="1">.47</td><td align="left" id="dom12947-ent-0316" valign="top" rowspan="1" colspan="1">.27</td></tr><tr><td id="dom12947-ent-0317" align="left" valign="top" rowspan="1" colspan="1">Protein<sub>fasting</sub>, g/min</td><td id="dom12947-ent-0318" align="left" valign="top" rowspan="1" colspan="1">1.13 (1.1, 1.2)</td><td id="dom12947-ent-0319" align="left" valign="top" rowspan="1" colspan="1">1.18 (1.1, 1.2)</td><td id="dom12947-ent-0320" align="left" valign="top" rowspan="1" colspan="1">1.15 (1.1, 1.2)</td><td id="dom12947-ent-0321" align="left" valign="top" rowspan="1" colspan="1">1.14 (1.1, 1.2)</td><td align="left" id="dom12947-ent-0322" valign="top" rowspan="1" colspan="1">.44</td><td align="left" id="dom12947-ent-0323" valign="top" rowspan="1" colspan="1">.25</td></tr><tr><td id="dom12947-ent-0324" align="left" valign="top" rowspan="1" colspan="1">Protein<sub>clamp</sub>, g/min</td><td id="dom12947-ent-0325" align="left" valign="top" rowspan="1" colspan="1">1.02 (1.0, 1.1)#</td><td id="dom12947-ent-0326" align="left" valign="top" rowspan="1" colspan="1">1.07 (1.0, 1.1)</td><td id="dom12947-ent-0327" align="left" valign="top" rowspan="1" colspan="1">1.11 (1.1, 1.1)</td><td id="dom12947-ent-0328" align="left" valign="top" rowspan="1" colspan="1">1.10 (1.1, 1.1)</td><td align="left" id="dom12947-ent-0329" valign="top" rowspan="1" colspan="1">.36</td><td align="left" id="dom12947-ent-0330" valign="top" rowspan="1" colspan="1">.22</td></tr></tbody></table><table-wrap-foot><fn id="dom12947-note-0008"><p>Abbreviation: REE, resting energy expenditure.</p></fn><fn id="dom12947-note-0009"><p>Values are means and 95% CIs.</p></fn><fn id="dom12947-note-0010"><label>a</label><p>Log transformation was done to achieve normal distribution.</p></fn><fn id="dom12947-note-0011"><p>#<styled-content style="italic-in-any-context">P</styled-content> &#x0003c; .05 difference between groups in corresponding time point. <styled-content style="italic-in-any-context">P</styled-content> value (training) indicates the mean changes in pre and post measurements in whole group, <styled-content style="italic-in-any-context">P</styled-content> value (training*BAT) indicates whether high BAT and low BAT groups behaved differently for the change in variable with significant difference between them.</p></fn></table-wrap-foot></table-wrap><fig fig-type="Figure" xml:lang="en" id="dom12947-fig-0003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Differences between high BAT and low BAT activity groups in insulin&#x02010;stimulated glucose uptake (GU) (A and B) and fasting FFA uptake rates (C and D) in muscle and different adipose tissue depots pre&#x02010; and post&#x02010;training. Data are means and (95% CI). #<styled-content style="italic-in-any-context">P</styled-content> &#x0003c; .0001 differences between the groups at baseline, *<styled-content style="italic-in-any-context">P</styled-content> = .02, **<styled-content style="italic-in-any-context">P</styled-content> = .0009 mean changes in pre&#x02010; and post&#x02010;measurements in whole group (training), &#x02020;<styled-content style="italic-in-any-context">P</styled-content> = .02, &#x02020;&#x02020;<styled-content style="italic-in-any-context">P</styled-content> = .01 indicates whether high BAT and low BAT activity groups behaved differently for the change in variable, with significant difference between them (training*BAT). QF, quadriceps femoris muscle; WAT(A), abdominal subcutaneous WAT; WAT(F), femoral subcutaneous WAT; VIS, abdominal visceral adipose tissue</p></caption><graphic id="nlm-graphic-5" xlink:href="DOM-19-1379-g003"/></fig></sec><sec id="dom12947-sec-0017"><label>3.3</label><title>Exercise training changes substrate metabolism in participants with high BAT and those with low BAT</title><p id="dom12947-para-0020">Two weeks of training decreased insulin&#x02010;stimulated BAT glucose uptake in participants with high BAT activity, whereas there was no change in participants with low BAT activity (training*BAT <italic>P</italic> = .02; Figure <xref rid="dom12947-fig-0002" ref-type="fig">2</xref>B,C). By contrast, training decreased BAT FFA uptake in the low BAT activity group, but not in the high BAT activity group (training*BAT <italic>P</italic> = .01; Figure <xref rid="dom12947-fig-0002" ref-type="fig">2</xref>D,E). There were also no changes in BAT mass or radiodensity (Table <xref rid="dom12947-tbl-0001" ref-type="table-wrap">1</xref>) before and after training. There was no association between the changes in BAT glucose uptake and changes in VO<sub>2peak</sub>, or between the changes in BAT glucose uptake and M&#x02010;value.</p><p id="dom12947-para-0021">Exercise training resulted in similar increases in quadriceps muscle glucose uptake in participants with both high and low BAT activity (training <italic>P</italic> = .0009, training *BAT, <italic>P</italic> = .25, Figure <xref rid="dom12947-fig-0003" ref-type="fig">3</xref>A). By contrast, exercise&#x02010;induced increases in glucose uptake in femoral WAT tended to be higher in the high BAT compared with the low BAT activity group (training <italic>P</italic> = .02; training*BAT <italic>P</italic> = .07; Figure <xref rid="dom12947-fig-0003" ref-type="fig">3</xref>B). Training had no effect on muscle FFA uptake in either group (Figure <xref rid="dom12947-fig-0003" ref-type="fig">3</xref>C). Interestingly, training affected IL&#x02010;6 concentrations differently in the high BAT and low BAT activity groups, with the high BAT activity group having an increase and the low BAT activity group having a decrease in IL&#x02010;6 (training*BAT <italic>P</italic> = .04; Table <xref rid="dom12947-tbl-0001" ref-type="table-wrap">1</xref>). Epinephrine concentrations increased in both groups after training (training <italic>P</italic> = .01, training*BAT <italic>P</italic> = .53; Table <xref rid="dom12947-tbl-0002" ref-type="table-wrap">2</xref>).</p></sec></sec><sec id="dom12947-sec-0018"><label>4</label><title>DISCUSSION</title><p id="dom12947-para-0022">We investigated the effects of short&#x02010;term exercise training (HIIT and MICT) on BAT metabolism in sedentary men using FTHA and FDG PET/CT&#x02010;scanning. Training increased aerobic capacity and muscle insulin sensitivity, but, interestingly, decreased BAT insulin&#x02010;stimulated glucose uptake in participants who had highly active BAT to start with. We also showed that participants with high BAT activity had a better metabolic profile compared with participants with low BAT activity before training.</p><p id="dom12947-para-0023">To our knowledge, this is the first study in which BAT metabolism has been quantitated before and after a controlled exercise training intervention. Contrary to our hypothesis, we found that 2 weeks of exercise training decreases insulin&#x02010;stimulated BAT glucose uptake in participants with high BAT activity before the intervention. Our results are in line with recent cross&#x02010;sectional data, showing reduced cold&#x02010;stimulated BAT glucose uptake in athletes compared with sedentary subjects.<xref rid="dom12947-bib-0009" ref-type="ref">9</xref> Notably, all the participants in the study by Vosselman et al.<xref rid="dom12947-bib-0009" ref-type="ref">9</xref> seemed to have high BAT activity based on 18&#x02010;FDG uptake values measured using semi&#x02010;quantitative standard uptake values. In the present study, instead of standard uptake values, we used quantitative dynamic PET data and performed an intervention study for sedentary participants.<xref rid="dom12947-bib-0016" ref-type="ref">16</xref> While most BAT glucose uptake studies in humans use cold exposure, we studied BAT glucose uptake during hyperinsulinaemia, which has been shown to be associated with cold&#x02010;induced BAT glucose uptake.<xref rid="dom12947-bib-0017" ref-type="ref">17</xref> Insulin stimulation has been shown to increase BAT glucose uptake 5&#x02010;fold compared with the fasting state at room temperature in people with functional BAT.<xref rid="dom12947-bib-0006" ref-type="ref">6</xref> Indeed, it can be speculated that the participants with high BAT have higher BAT insulin sensitivity.</p><p id="dom12947-para-0024">Although the intervention period in the present study was short, it markedly increased the aerobic capacity and the insulin&#x02010;stimulated muscle glucose uptake (muscle insulin sensitivity). As BAT is an insulin&#x02010;sensitive tissue, we hypothesized that training would also improve the BAT insulin sensitivity (BAT glucose uptake during insulin stimulation). Interestingly, the results showed that training decreased BAT glucose uptake in the group with higher BAT insulin sensitivity at baseline. BAT is probably not a source of energy during exercise; thus, the question arises of why the human body would reduce BAT substrate uptake after training. We found no change in whole&#x02010;body energy consumption and only a tendency towards improved whole&#x02010;body insulin sensitivity; thus, to maintain whole&#x02010;body homeostasis, one reason for the decreased BAT glucose uptake after the exercise training might be that the body decreases BAT glucose uptake in order to provide substrate to the increased skeletal muscle glucose uptake;<xref rid="dom12947-bib-0018" ref-type="ref">18</xref>, <xref rid="dom12947-bib-0019" ref-type="ref">19</xref> however, when we tested skeletal muscle glucose uptake as a covariate, we found that the change in skeletal muscle glucose uptake did not explain the decrease in BAT glucose uptake.</p><p id="dom12947-para-0025">In rodents, we have shown that exercise&#x02010;trained rats have more glycogen in BAT compared with non&#x02010;trained animals (Jessen and Goodyear, unpublished data). Thus, if this is also true in humans, the increased glycogen levels post&#x02010;training may inhibit the insulin&#x02010;stimulated glucose uptake into BAT, explaining the observed reduction in BAT glucose uptake after the training in the present study.</p><p id="dom12947-para-0026">In rats, 8 weeks of endurance training decreased BAT mass, UCP&#x02010;1 expression, and BAT thermogenic activity.<xref rid="dom12947-bib-0020" ref-type="ref">20</xref> Thus, it was suggested that the changes in BAT activity after exercise may be attributable to a decreased need for BAT heat production since, during exercise, working muscles produce excess heat.<xref rid="dom12947-bib-0020" ref-type="ref">20</xref> In the present study, we did not find any correlation between BAT glucose uptake and BAT mass at baseline or a change in BAT mass after 2 weeks of training intervention.</p><p id="dom12947-para-0027">The radiodensity of BAT is used as a marker of BAT intracellular triglyceride content.<xref rid="dom12947-bib-0021" ref-type="ref">21</xref> Lower BAT radiodensity in overweight people with type 2 diabetes compared with healthy lean control subjects has been suggested to indicate a shift towards BAT lipid storage or a lipolytic dysfunction of BAT.<xref rid="dom12947-bib-0022" ref-type="ref">22</xref>, <xref rid="dom12947-bib-0023" ref-type="ref">23</xref> Acute cold exposure increases BAT radiodensity, indicating a decrease in BAT lipid content.<xref rid="dom12947-bib-0021" ref-type="ref">21</xref>, <xref rid="dom12947-bib-0024" ref-type="ref">24</xref> We did not find any change in BAT radiodensity, suggesting no exercise&#x02010;induced effect on BAT lipid content.</p><p id="dom12947-para-0028">We found that exercise training increased skeletal muscle insulin&#x02010;stimulated glucose uptake, but not FFA uptake, which is consistent with previous data.<xref rid="dom12947-bib-0018" ref-type="ref">18</xref>, <xref rid="dom12947-bib-0025" ref-type="ref">25</xref> Here, we also found that insulin&#x02010;stimulated glucose uptake increased in femoral subcutaneous adipose tissue, and the improvement tended to be higher in the HIIT than in the MICT group. Previously, moderate&#x02010; or high&#x02010;intensity exercise training has not been found to directly improve insulin&#x02010;stimulated glucose uptake in the abdominal or femoral subcutaneous adipose tissue; however, adipose tissue GLUT4 protein expression has been shown to increase in people with type 2 diabetes after 4 weeks of bicycle training<xref rid="dom12947-bib-0026" ref-type="ref">26</xref> and previous cross&#x02010;sectional studies show that endurance athletes have higher abdominal subcutaneous adipose tissue insulin sensitivity than untrained subjects.<xref rid="dom12947-bib-0027" ref-type="ref">27</xref> It is noteworthy that, in the present study, the insulin&#x02010;stimulated glucose uptake increased only in femoral subcutaneous adipose tissue and not in other fat depots. Femoral subcutaneous adipose tissue is not involved in muscle contraction as such, but is located in close vicinity to the exercising muscles. It is possible, therefore, that exercising skeletal muscles releases myokines to local adipose tissue depots,<xref rid="dom12947-bib-0019" ref-type="ref">19</xref> which may mediate local adipose tissue glucose uptake.</p><p id="dom12947-para-0029">Interestingly, after stratifying participants based on our previously defined cut&#x02010;off criteria for BAT activity, we found that those with high BAT and those with low BAT had clear differences in baseline characteristics before the training intervention. The high BAT group in the present study had lower body adiposity and visceral fat mass, along with markedly higher insulin sensitivity and HDL cholesterol concentration, which have all been shown to associate with BAT glucose uptake.<xref rid="dom12947-bib-0004" ref-type="ref">4</xref>, <xref rid="dom12947-bib-0028" ref-type="ref">28</xref>, <xref rid="dom12947-bib-0029" ref-type="ref">29</xref>, <xref rid="dom12947-bib-0030" ref-type="ref">30</xref>, <xref rid="dom12947-bib-0031" ref-type="ref">31</xref> The high BAT group also had higher whole&#x02010;body and muscle insulin sensitivity, as well as higher carbohydrate and lower fat oxidation during hyperinsulinaemia, indicating improved metabolic flexibility in changing from fat oxidation during fasting to carbohydrate oxidation during hyperinsulinaemia. These data support the concept that high baseline BAT activity may protect against adiposity and insulin resistance.</p><p id="dom12947-para-0030">The high BAT group also had lower levels of IL&#x02010;6 and leptin, possibly as a result of lower body adiposity and higher levels of MCP&#x02010;1. IL&#x02010;6 and MCP&#x02010;1 are secreted from macrophages, among other tissues, and can have both pro&#x02010; and anti&#x02010;inflammatory effects. Elevated levels of these cytokines associate with insulin resistance and are seen in obesity and type 2 diabetes in humans.<xref rid="dom12947-bib-0032" ref-type="ref">32</xref>, <xref rid="dom12947-bib-0033" ref-type="ref">33</xref> In line with previous studies, the high BAT activity group had lower levels of leptin compared with the low BAT activity group in the present study.<xref rid="dom12947-bib-0034" ref-type="ref">34</xref> Indeed, the present study cannot determine whether high BAT activity contributes to a positive profile of adipokines or the opposite; however, the present study highlights that BAT can be a key player in metabolic regulation and a possible target for pharmacological treatment of insulin resistance.</p><p id="dom12947-para-0031">In rodents, BAT has been shown to secrete IL&#x02010;6, and exercise&#x02010;induced IL&#x02010;6 activates subcutaneous adipose tissue beiging.<xref rid="dom12947-bib-0035" ref-type="ref">35</xref> Stanford et al.<xref rid="dom12947-bib-0036" ref-type="ref">36</xref> have shown that BAT transplantation into the visceral cavity in mice increased circulating IL&#x02010;6 levels, which was accompanied by enhanced energy consumption, reduced adiposity and improved glucose homeostasis in the recipient wild&#x02010;type but not in IL&#x02010;6 knockout mice, indicating that these effects were IL&#x02010;6&#x02010;dependent. They hypothesized that the IL&#x02010;6&#x02010;dependent effects may lead to the promotion of lipolysis and increased insulin sensitivity in WAT and the heart through an increase in GLUT1 protein expression.<xref rid="dom12947-bib-0036" ref-type="ref">36</xref> In contrast to our findings, Vosselman et al.<xref rid="dom12947-bib-0009" ref-type="ref">9</xref> did not find a correlation between IL&#x02010;6 and cold&#x02010;induced BAT activity in humans.<xref rid="dom12947-bib-0009" ref-type="ref">9</xref> Thus, the role of IL&#x02010;6 in BAT metabolism and function in humans warrants further investigation.</p><p id="dom12947-para-0032">In summary, the present study suggests that humans with active BAT exhibit a metabolically more favourable phenotype compared with those without active BAT. BAT appears to behave differently from skeletal muscle in response to short&#x02010;term exercise training, decreasing insulin&#x02010;stimulated BAT glucose uptake. Thus, exercise training may downregulate BAT glucose metabolism in humans. The physiological role for the decreased BAT activation with exercise training will be important to understand given the attention to developing novel activators of BAT for increased energy expenditure and weight loss. The number of participants in the present study was small, and further investigations are warranted to confirm its findings.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material content-type="local-data" id="dom12947-supitem-0001"><caption><p>Supporting Information</p></caption><media xlink:href="DOM-19-1379-s001.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack id="dom12947-sec-0019"><title>ACKNOWLEDGEMENTS</title><p id="dom12947-para-0033">We thank all the volunteers who participated in this study, the study nurse Mikko Koivum&#x000e4;ki, and the staff of the Turku PET Centre and Paavo Nurmi Centre for their excellent assistance in the study.</p><sec id="dom12947-sec-0020" sec-type="COI-statement"><title>Conflict of interest</title><p id="dom12947-para-0034">None of the authors has any conflict of interest regarding any aspect of this manuscript.</p></sec><sec id="dom12947-sec-0021"><title>Author contributions</title><p id="dom12947-para-0035">P. M. contributed to the analysis, results interpretation and writing of the manuscript. V. S., J. J. E., R. J. M., A. M., J. C. H., K. A. V. and J. K. contributed to the acquisition of data. K. K. M., J. J. E., E. L., R. J. M., M. U. D. contributed to data analysis. P. N., L. J. G., R. J. M., J. J., R. P., J. K. and K. K. K. contributed to the study design and critical revision of the manuscript for important intellectual content. J. C. H. contributed to the study design, writing and drafting the manuscript. All authors approved the last version of the manuscript. J. C. H. is the guarantor of this work and, as such, had access to all study data and takes responsibility for the integrity of the data and the data analysis.</p></sec></ack><ref-list content-type="cited-references" id="dom12947-bibl-0001"><title>REFERENCES</title><ref id="dom12947-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="dom12947-cit-0001">
<string-name>
<surname>Villarroya</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Cereijo</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Villarroya</surname>
<given-names>F</given-names>
</string-name>. <article-title>An endocrine role for brown adipose tissue?</article-title>
<source>Am J Physiol Endocrinol Metab</source>. <year>2013</year>;<volume>305</volume>:<fpage>E567</fpage>&#x02010;<lpage>E572</lpage>.<pub-id pub-id-type="pmid">23839524</pub-id></mixed-citation></ref><ref id="dom12947-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="dom12947-cit-0002">
<string-name>
<surname>Klaus</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Casteilla</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Bouillaud</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Ricquier</surname>
<given-names>D</given-names>
</string-name>. <article-title>The uncoupling protein UCP: a membraneous mitochondrial ion carrier exclusively expressed in brown adipose tissue</article-title>. <source>Int J Biochem</source>. <year>1991</year>;<volume>23</volume>:<fpage>791</fpage>&#x02010;<lpage>801</lpage>.<pub-id pub-id-type="pmid">1773883</pub-id></mixed-citation></ref><ref id="dom12947-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="dom12947-cit-0003">
<string-name>
<surname>Cinti</surname>
<given-names>S</given-names>
</string-name>. <article-title>The role of brown adipose tissue in human obesity</article-title>. <source>Nutr Metab Cardiovasc Dis</source>. <year>2006</year>;<volume>16</volume>:<fpage>569</fpage>&#x02010;<lpage>574</lpage>.<pub-id pub-id-type="pmid">17113764</pub-id></mixed-citation></ref><ref id="dom12947-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="dom12947-cit-0004">
<string-name>
<surname>Chondronikola</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Volpi</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Borsheim</surname>
<given-names>E</given-names>
</string-name>, et al. <article-title>Brown adipose tissue improves whole&#x02010;body glucose homeostasis and insulin sensitivity in humans</article-title>. <source>Diabetes</source>. <year>2014</year>;<volume>63</volume>:<fpage>4089</fpage>&#x02010;<lpage>4099</lpage>.<pub-id pub-id-type="pmid">25056438</pub-id></mixed-citation></ref><ref id="dom12947-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="dom12947-cit-0005">
<string-name>
<surname>Virtanen</surname>
<given-names>KA</given-names>
</string-name>, <string-name>
<surname>Lidell</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Orava</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Functional brown adipose tissue in healthy adults</article-title>. <source>N Engl J Med</source>. <year>2009</year>;<volume>360</volume>:<fpage>1518</fpage>&#x02010;<lpage>1525</lpage>.<pub-id pub-id-type="pmid">19357407</pub-id></mixed-citation></ref><ref id="dom12947-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="dom12947-cit-0006">
<string-name>
<surname>Orava</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Nuutila</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Lidell</surname>
<given-names>ME</given-names>
</string-name>, et al. <article-title>Different metabolic responses of human brown adipose tissue to activation by cold and insulin</article-title>. <source>Cell Metab</source>. <year>2011</year>;<volume>14</volume>:<fpage>272</fpage>&#x02010;<lpage>279</lpage>.<pub-id pub-id-type="pmid">21803297</pub-id></mixed-citation></ref><ref id="dom12947-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="dom12947-cit-0007">
<string-name>
<surname>Eskelinen</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Heinonen</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Loyttyniemi</surname>
<given-names>E</given-names>
</string-name>, et al. <article-title>Muscle&#x02010;specific glucose and free fatty acid uptake after sprint interval and moderate&#x02010;intensity training in healthy middle&#x02010;aged men</article-title>. <source>J Appl Physiol (1985)</source>. <year>2015</year>;<volume>118</volume>:<fpage>1172</fpage>&#x02010;<lpage>1180</lpage>.<pub-id pub-id-type="pmid">25767035</pub-id></mixed-citation></ref><ref id="dom12947-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="dom12947-cit-0008">
<string-name>
<surname>Dinas</surname>
<given-names>PC</given-names>
</string-name>, <string-name>
<surname>Nikaki</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Jamurtas</surname>
<given-names>AZ</given-names>
</string-name>, et al. <article-title>Association between habitual physical activity and brown adipose tissue activity in individuals undergoing PET&#x02010;CT scan</article-title>. <source>Clin Endocrinol (Oxf)</source>. <year>2015</year>;<volume>82</volume>:<fpage>147</fpage>&#x02010;<lpage>154</lpage>.<pub-id pub-id-type="pmid">25262810</pub-id></mixed-citation></ref><ref id="dom12947-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="dom12947-cit-0009">
<string-name>
<surname>Vosselman</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Hoeks</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Brans</surname>
<given-names>B</given-names>
</string-name>, et al. <article-title>Low brown adipose tissue activity in endurance trained compared to lean sedentary men</article-title>. <source>Int J Obes (Lond)</source>. <year>2015</year>;<volume>39</volume>:<fpage>1696</fpage>&#x02010;<lpage>1702</lpage>.<pub-id pub-id-type="pmid">26189600</pub-id></mixed-citation></ref><ref id="dom12947-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="dom12947-cit-0010">
<string-name>
<surname>Kiviniemi</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Tulppo</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Eskelinen</surname>
<given-names>JJ</given-names>
</string-name>, et al. <article-title>Cardiac autonomic function and high&#x02010;intensity interval training in middle&#x02010;age men</article-title>. <source>Med Sci Sports Exerc</source>. <year>2014</year>;<volume>46</volume>:<fpage>1960</fpage>&#x02010;<lpage>1967</lpage>.<pub-id pub-id-type="pmid">24561814</pub-id></mixed-citation></ref><ref id="dom12947-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="dom12947-cit-0011">
<string-name>
<surname>Merilainen</surname>
<given-names>PT</given-names>
</string-name>. <article-title>Metabolic monitor</article-title>. <source>Int J Clin Monit Comput</source>. <year>1987</year>;<volume>4</volume>:<fpage>167</fpage>&#x02010;<lpage>177</lpage>.<pub-id pub-id-type="pmid">3116131</pub-id></mixed-citation></ref><ref id="dom12947-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="dom12947-cit-0012">
<string-name>
<surname>Harris</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Benedict</surname>
<given-names>FG</given-names>
</string-name>. <article-title>A biometric study of human basal metabolism</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>1918</year>;<volume>4</volume>:<fpage>370</fpage>&#x02010;<lpage>373</lpage>.<pub-id pub-id-type="pmid">16576330</pub-id></mixed-citation></ref><ref id="dom12947-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="dom12947-cit-0013">
<string-name>
<surname>Ouellet</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Routhier&#x02010;Labadie</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bellemare</surname>
<given-names>W</given-names>
</string-name>, et al. <article-title>Outdoor temperature, age, sex, body mass index, and diabetic status determine the prevalence, mass, and glucose&#x02010;uptake activity of 18 F&#x02010;FDG&#x02010;detected BAT in humans</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2011</year>;<volume>96</volume>:<fpage>192</fpage>&#x02010;<lpage>199</lpage>.<pub-id pub-id-type="pmid">20943785</pub-id></mixed-citation></ref><ref id="dom12947-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="dom12947-cit-0014">
<string-name>
<surname>Muzik</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Mangner</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Leonard</surname>
<given-names>WR</given-names>
</string-name>, <string-name>
<surname>Kumar</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Janisse</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Granneman</surname>
<given-names>JG</given-names>
</string-name>. <article-title>15O PET measurement of blood flow and oxygen consumption in cold&#x02010;activated human brown fat</article-title>. <source>J Nucl Med</source>. <year>2013</year>;<volume>54</volume>:<fpage>523</fpage>&#x02010;<lpage>531</lpage>.<pub-id pub-id-type="pmid">23362317</pub-id></mixed-citation></ref><ref id="dom12947-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="dom12947-cit-0015">
<string-name>
<surname>Abate</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Burns</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Peshock</surname>
<given-names>RM</given-names>
</string-name>, <string-name>
<surname>Garg</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Grundy</surname>
<given-names>SM</given-names>
</string-name>. <article-title>Estimation of adipose tissue mass by magnetic resonance imaging: validation against dissection in human cadavers</article-title>. <source>J Lipid Res</source>. <year>1994</year>;<volume>35</volume>:<fpage>1490</fpage>&#x02010;<lpage>1496</lpage>.<pub-id pub-id-type="pmid">7989873</pub-id></mixed-citation></ref><ref id="dom12947-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="dom12947-cit-0016">
<string-name>
<surname>Muzi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>O'Sullivan</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Mankoff</surname>
<given-names>DA</given-names>
</string-name>, et al. <article-title>Quantitative assessment of dynamic PET imaging data in cancer imaging</article-title>. <source>Magn Reson Imaging</source>. <year>2012</year>;<volume>30</volume>:<fpage>1203</fpage>&#x02010;<lpage>1215</lpage>.<pub-id pub-id-type="pmid">22819579</pub-id></mixed-citation></ref><ref id="dom12947-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="dom12947-cit-0017">
<string-name>
<surname>Orava</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Nuutila</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Noponen</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>Blunted metabolic responses to cold and insulin stimulation in brown adipose tissue of obese humans</article-title>. <source>Obesity (Silver Spring)</source>. <year>2013</year>;<volume>21</volume>:<fpage>2279</fpage>&#x02010;<lpage>2287</lpage>.<pub-id pub-id-type="pmid">23554353</pub-id></mixed-citation></ref><ref id="dom12947-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="dom12947-cit-0018">
<string-name>
<surname>Reichkendler</surname>
<given-names>MH</given-names>
</string-name>, <string-name>
<surname>Auerbach</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Rosenkilde</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Exercise training favors increased insulin&#x02010;stimulated glucose uptake in skeletal muscle in contrast to adipose tissue: a randomized study using FDG PET imaging</article-title>. <source>Am J Physiol Endocrinol Metab</source>. <year>2013</year>;<volume>305</volume>:<fpage>E496</fpage>&#x02010;<lpage>E506</lpage>.<pub-id pub-id-type="pmid">23800880</pub-id></mixed-citation></ref><ref id="dom12947-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="dom12947-cit-0019">
<string-name>
<surname>Pedersen</surname>
<given-names>BK</given-names>
</string-name>, <string-name>
<surname>Akerstrom</surname>
<given-names>TC</given-names>
</string-name>, <string-name>
<surname>Nielsen</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Fischer</surname>
<given-names>CP</given-names>
</string-name>. <article-title>Role of myokines in exercise and metabolism</article-title>. <source>J Appl Physiol (1985)</source>. <year>2007</year>;<volume>103</volume>:<fpage>1093</fpage>&#x02010;<lpage>1098</lpage>.<pub-id pub-id-type="pmid">17347387</pub-id></mixed-citation></ref><ref id="dom12947-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="dom12947-cit-0020">
<string-name>
<surname>Wu</surname>
<given-names>MV</given-names>
</string-name>, <string-name>
<surname>Bikopoulos</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Hung</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ceddia</surname>
<given-names>RB</given-names>
</string-name>. <article-title>Thermogenic capacity is antagonistically regulated in classical brown and white subcutaneous fat depots by high fat diet and endurance training in rats: impact on whole&#x02010;body energy expenditure</article-title>. <source>J Biol Chem</source>. <year>2014</year>;<volume>289</volume>:<fpage>34129</fpage>&#x02010;<lpage>34140</lpage>.<pub-id pub-id-type="pmid">25344623</pub-id></mixed-citation></ref><ref id="dom12947-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="dom12947-cit-0021">
<string-name>
<surname>Ouellet</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Labbe</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Blondin</surname>
<given-names>DP</given-names>
</string-name>, et al. <article-title>Brown adipose tissue oxidative metabolism contributes to energy expenditure during acute cold exposure in humans</article-title>. <source>J Clin Invest</source>. <year>2012</year>;<volume>122</volume>:<fpage>545</fpage>&#x02010;<lpage>552</lpage>.<pub-id pub-id-type="pmid">22269323</pub-id></mixed-citation></ref><ref id="dom12947-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="dom12947-cit-0022">
<string-name>
<surname>Blondin</surname>
<given-names>DP</given-names>
</string-name>, <string-name>
<surname>Labbe</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Noll</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Selective impairment of glucose but not fatty acid or oxidative metabolism in brown adipose tissue of subjects with type 2 diabetes</article-title>. <source>Diabetes</source>. <year>2015</year>;<volume>64</volume>:<fpage>2388</fpage>&#x02010;<lpage>2397</lpage>.<pub-id pub-id-type="pmid">25677914</pub-id></mixed-citation></ref><ref id="dom12947-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="dom12947-cit-0023">
<string-name>
<surname>Pasarica</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sereda</surname>
<given-names>OR</given-names>
</string-name>, <string-name>
<surname>Redman</surname>
<given-names>LM</given-names>
</string-name>, et al. <article-title>Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response</article-title>. <source>Diabetes</source>. <year>2009</year>;<volume>58</volume>:<fpage>718</fpage>&#x02010;<lpage>725</lpage>.<pub-id pub-id-type="pmid">19074987</pub-id></mixed-citation></ref><ref id="dom12947-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="dom12947-cit-0024">
<string-name>
<surname>Baba</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Jacene</surname>
<given-names>HA</given-names>
</string-name>, <string-name>
<surname>Engles</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Honda</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Wahl</surname>
<given-names>RL</given-names>
</string-name>. <article-title>CT Hounsfield units of brown adipose tissue increase with activation: preclinical and clinical studies</article-title>. <source>J Nucl Med</source>. <year>2010</year>;<volume>51</volume>:<fpage>246</fpage>&#x02010;<lpage>250</lpage>.<pub-id pub-id-type="pmid">20124047</pub-id></mixed-citation></ref><ref id="dom12947-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="dom12947-cit-0025">
<string-name>
<surname>Hannukainen</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Nuutila</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Kaprio</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Relationship between local perfusion and FFA uptake in human skeletal muscle&#x02010;no effect of increased physical activity and aerobic fitness</article-title>. <source>J Appl Physiol (1985)</source>. <year>2006</year>;<volume>101</volume>:<fpage>1303</fpage>&#x02010;<lpage>1311</lpage>.<pub-id pub-id-type="pmid">16825528</pub-id></mixed-citation></ref><ref id="dom12947-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="dom12947-cit-0026">
<string-name>
<surname>Hussey</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>McGee</surname>
<given-names>SL</given-names>
</string-name>, <string-name>
<surname>Garnham</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Wentworth</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Jeukendrup</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Hargreaves</surname>
<given-names>M</given-names>
</string-name>. <article-title>Exercise training increases adipose tissue GLUT4 expression in patients with type 2 diabetes</article-title>. <source>Diabetes Obes Metab</source>. <year>2011</year>;<volume>13</volume>:<fpage>959</fpage>&#x02010;<lpage>962</lpage>.<pub-id pub-id-type="pmid">21615668</pub-id></mixed-citation></ref><ref id="dom12947-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="dom12947-cit-0027">
<string-name>
<surname>Stallknecht</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Larsen</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Mikines</surname>
<given-names>KJ</given-names>
</string-name>, <string-name>
<surname>Simonsen</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Bulow</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Galbo</surname>
<given-names>H</given-names>
</string-name>. <article-title>Effect of training on insulin sensitivity of glucose uptake and lipolysis in human adipose tissue</article-title>. <source>Am J Physiol Endocrinol Metab</source>. <year>2000</year>;<volume>279</volume>:<fpage>E376</fpage>&#x02010;<lpage>E385</lpage>.<pub-id pub-id-type="pmid">10913038</pub-id></mixed-citation></ref><ref id="dom12947-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="dom12947-cit-0028">
<string-name>
<surname>Saito</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Okamatsu&#x02010;Ogura</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Matsushita</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity</article-title>. <source>Diabetes</source>. <year>2009</year>;<volume>58</volume>:<fpage>1526</fpage>&#x02010;<lpage>1531</lpage>.<pub-id pub-id-type="pmid">19401428</pub-id></mixed-citation></ref><ref id="dom12947-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="dom12947-cit-0029">
<string-name>
<surname>Matsushita</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Yoneshiro</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Aita</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kameya</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Sugie</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Saito</surname>
<given-names>M</given-names>
</string-name>. <article-title>Impact of brown adipose tissue on body fatness and glucose metabolism in healthy humans</article-title>. <source>Int J Obes (Lond)</source>. <year>2014</year>;<volume>38</volume>:<fpage>812</fpage>&#x02010;<lpage>817</lpage>.<pub-id pub-id-type="pmid">24213309</pub-id></mixed-citation></ref><ref id="dom12947-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="dom12947-cit-0030">
<string-name>
<surname>Wang</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Brown adipose tissue activation is inversely related to central obesity and metabolic parameters in adult human</article-title>. <source>PLoS ONE</source>. <year>2015</year>;<volume>10</volume>:<fpage>e0123795</fpage>.<pub-id pub-id-type="pmid">25894250</pub-id></mixed-citation></ref><ref id="dom12947-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="dom12947-cit-0031">
<string-name>
<surname>Cypess</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Lehman</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Williams</surname>
<given-names>G</given-names>
</string-name>, et al. <article-title>Identification and importance of brown adipose tissue in adult humans</article-title>. <source>N Engl J Med</source>. <year>2009</year>;<volume>360</volume>:<fpage>1509</fpage>&#x02010;<lpage>1517</lpage>.<pub-id pub-id-type="pmid">19357406</pub-id></mixed-citation></ref><ref id="dom12947-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="dom12947-cit-0032">
<string-name>
<surname>Dela</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Stallknecht</surname>
<given-names>B</given-names>
</string-name>. <article-title>Effect of physical training on insulin secretion and action in skeletal muscle and adipose tissue of first&#x02010;degree relatives of type 2 diabetic patients</article-title>. <source>Am J Physiol Endocrinol Metab</source>. <year>2010</year>;<volume>299</volume>:<fpage>E80</fpage>&#x02010;<lpage>E91</lpage>.<pub-id pub-id-type="pmid">20407006</pub-id></mixed-citation></ref><ref id="dom12947-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="dom12947-cit-0033">
<string-name>
<surname>Wellen</surname>
<given-names>KE</given-names>
</string-name>, <string-name>
<surname>Hotamisligil</surname>
<given-names>GS</given-names>
</string-name>. <article-title>Obesity&#x02010;induced inflammatory changes in adipose tissue</article-title>. <source>J Clin Invest</source>. <year>2003</year>;<volume>112</volume>:<fpage>1785</fpage>&#x02010;<lpage>1788</lpage>.<pub-id pub-id-type="pmid">14679172</pub-id></mixed-citation></ref><ref id="dom12947-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="dom12947-cit-0034">
<string-name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Ye</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Miao</surname>
<given-names>Q</given-names>
</string-name>, et al. <article-title>Differences in the metabolic status of healthy adults with and without active brown adipose tissue</article-title>. <source>Wien Klin Wochenschr</source>. <year>2013</year>;<volume>125</volume>:<fpage>687</fpage>&#x02010;<lpage>695</lpage>.<pub-id pub-id-type="pmid">24146327</pub-id></mixed-citation></ref><ref id="dom12947-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="dom12947-cit-0035">
<string-name>
<surname>Knudsen</surname>
<given-names>JG</given-names>
</string-name>, <string-name>
<surname>Murholm</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Carey</surname>
<given-names>AL</given-names>
</string-name>, et al. <article-title>Role of IL&#x02010;6 in exercise training&#x02010; and cold&#x02010;induced UCP1 expression in subcutaneous white adipose tissue</article-title>. <source>PLoS ONE</source>. <year>2014</year>;<volume>9</volume>:<fpage>e84910</fpage>.<pub-id pub-id-type="pmid">24416310</pub-id></mixed-citation></ref><ref id="dom12947-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="dom12947-cit-0036">
<string-name>
<surname>Stanford</surname>
<given-names>KI</given-names>
</string-name>, <string-name>
<surname>Middelbeek</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Townsend</surname>
<given-names>KL</given-names>
</string-name>, et al. <article-title>Brown adipose tissue regulates glucose homeostasis and insulin sensitivity</article-title>. <source>J Clin Invest</source>. <year>2013</year>;<volume>123</volume>:<fpage>215</fpage>&#x02010;<lpage>223</lpage>.<pub-id pub-id-type="pmid">23221344</pub-id></mixed-citation></ref></ref-list></back></article>